Podcasts about american colleges

Learn how the 2026 tax law changes impact charitable deductions, SALT limits, and QCD planning—especially for donors over age 70½ and high-income taxpayers. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

Dr. Randy Blakely is a Professor of Biomedical Science at Florida Atlantic University and Executive Director of the Florida Atlantic University Brain Institute. Randy is examining how neurons control neurotransmitter signaling, as well as how medicinal drugs and drugs of abuse impact neurotransmitters. He is interested in how normal neurotransmitter regulation and changes in neurotransmission due to drugs ultimately impact behavior. Randy lives in beautiful South Florida near the Everglades, and he likes to spend is free time enjoying nature and observing the local wildlife. While commuting between campuses, Randy listens to a variety of audiobooks, and he is also a big fan of Americana and folk music. He received his B.A. in Philosophy from Emory University and his Ph.D. in Neuroscience from the Johns Hopkins School of Medicine. He next conducted postdoctoral research at the Yale/Howard Hughes Medical Institute Center for Molecular Neuroscience. Randy was an investigator and faculty member at Emory University and Vanderbilt University before accepting his current position at Florida Atlantic University. Randy is the recipient of numerous awards and honors for his research and mentorship. He was awarded the Daniel Efron Award from the American College of Neuropsychopharmacology, two Distinguished Investigator Awards from the Brain and Behavioral Research Foundation, a MERIT Award from the National Institute of Mental Health, a Zenith Award from the Alzheimer's Association, the Delores C. Shockley Partnership Award in recognition of minority trainee mentorship, as well as the Astellas Award in Translational Pharmacology and the Julius Axelrod Award both from the American Society for Pharmacology and Experimental Therapeutics. In addition, he is a Fellow of the American Academy for the Advancement of Science. Randy joins us in this episode to talk more about his life and science.

Listen as our Med Student Over Easy Hosts, Molly, Kaitlin and Patricia discuss how to tackle the idea of planning your 4th year. Don't forget our parent show is the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more about this organization and how you can see your favorite EM podcast LIVE and in person.

Show NotesLearn more about the Healthy Christian Woman Bootcamp: https://www.healthyformypurpose.com/healthy-christian-woman-bootcamp Check out our FREE Weight Loss Masterclass. Sign up today! https://www.healthyformypurpose.com/weight-loss-masterclass-opt-in-podcast In this deeply moving and power-packed conversation, we sit down with Terri Edwards, creator of EatPlant-Based.com, to explore her incredible journey from chronic pain, health struggles, and discouragement to renewed health, vibrant purpose, and bold faith. Terri shares how a plant-based lifestyle radically transformed her body, restored her vitality, strengthened her marriage, and ultimately led her into a God-given calling to serve others—through medical centers, classrooms, and now a thriving online food blog. We dive into her healing journey, how God opened impossible doors, why she boldly integrated faith into her platform, the resistance she faced, and why she believes God is moving powerfully in this season to bring believers to better health so they can fully live out their purpose. Get ready for truth, inspiration, and holy goosebumps. About Terri: Terri Edwards is the content creator behind the website EatPlant-Based and a licensed Food for Life instructor with the Physicians Committee for Responsible Medicine. After overcoming her own health challenges by adopting a plant-based lifestyle in 2013, she made it her mission to share the healing power of food. Terri has taught nutrition and cooking classes at hospitals, cancer centers, and medical offices throughout the Carolinas. Her blog, EatPlant-Based, is an oasis for those seeking wellness and restored health through scientifically proven plant-based nutrition. It features nourishing recipes, practical kitchen tips, and up-to-date insights from nutrition science. Through her teaching, writing, and faith-driven mission, Terri continues to inspire others to discover how whole-food, plant-based living can transform both body and spirit. Get recipes: https://eatplant-based.com/ Facebook: https://www.facebook.com/EatPlantBased Pinterest: https://www.pinterest.com/eatplantbased/ Instagram: https://www.instagram.com/eatplantbased.com14/ Twitter/X: https://x.com/EatPlantBasedTE About Sersie & Gigi The Healthy for My Purpose Podcast is designed to inspire you to reclaim your health and invite God into your health journey. This podcast will help you connect being healthy to your divine purpose. You will walk away seeing your health as a spiritual practice. Sersie Blue is a faith-based health coach and seminary graduate (MDiv in Counseling). Gigi Carter is a Certified Nutritionist (MS), Diplomate and Certified Lifestyle Medicine Professional through the American College of Lifestyle Medicine. These ladies are passionate about sharing the power of plant-based nutrition and faith. Music Credit: Bliss by Luke Bergs / bergscloud Creative Commons — Attribution-ShareAlike 3.0 Unported — CC BY-SA 3.0 Free Download / Stream: https://bit.ly/33DJFs9 Music promoted by Audio Library • Bliss – Luke Bergs (No Copyright Music)

Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. For years, fentanyl has dominated headlines as a driving force behind America's overdose crisis. What's discussed far less often is how this drug impacts the first responders who encounter it in the line of duty. For Deputy Jeff Brown, a long-serving law enforcement officer, accidental fentanyl exposure didn't just spark a frightening moment, it caused permanent injuries, ongoing trauma, and a new mission focused on helping others. The Law Enforcement Talk Radio Show and Podcast on social media like their Facebook , Instagram , LinkedIn , Medium and other social media platforms. By any measure, Jeff Brown is a law enforcement hero. But one accidental fentanyl exposure nearly ended his life, and forever changed it. This special episode is streaming for free on the Law Enforcement Talk Radio Show and Podcast website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform This is not just a story for the news-cycle. It's a story meant to be shared on Facebook, Instagram, YouTube, and across platforms like the Law Enforcement Talk Radio Show and Podcast website, Apple Podcasts and Spotify, because it speaks to the hidden cost of service, the reality of trauma, stress, PTSD, and the lasting injuries many heroes carry long after the call ends. Supporting articles about this and much more from Law Enforcement Talk Radio Show and Podcast in platforms like Medium , Blogspot and Linkedin . Accidental Fentanyl Exposure Almost Claimed His Life Jeff Brown had built a distinguished law enforcement career when one routine encounter with drug abusers turned into a life-threatening emergency. During the incident, Jeff and his backup deputies were accidentally exposed to fentanyl. The effects were immediate and terrifying. Had it not been for department-issued Narcan and the training the deputies received, Jeff believes he and others would not have survived. In a matter of minutes, deputies were forced to save each other's lives. Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. Look for The Law Enforcement Talk Radio Show and Podcast on social media like their Facebook , Instagram , LinkedIn , Medium and other social media platforms. They lived, but not without consequence. For Jeff, the exposure caused permanent damage to his heart, altering his health and his future. What should have been just another shift became the defining moment of his life. The Aftermath: Injuries, Recovery, and a Broken System Surviving the incident was only the beginning. Jeff openly talks about: The physical recovery and lingering medical issues The emotional toll and ongoing stress Battles with Worker's Compensation The lack of understanding surrounding first responder injuries The rarely discussed crime problem in a tourist-driven resort area Like many first responders, Jeff learned that surviving the job does not guarantee support afterward. The system often struggles to recognize invisible injuries, especially when fear, misinformation, and stigma surround incidents involving fentanyl. Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. Available for free on their website and streaming on Apple Podcasts, Spotify, Youtube and other podcast platforms. Fentanyl Misinformation and First Responder Trauma In 2016, the U.S. Drug Enforcement Administration (DEA) released advisories warning that simply touching or inhaling fentanyl could be fatal within minutes. Images of tiny, allegedly lethal doses circulated widely, reinforcing fear among first responders. At the time, the narrative felt plausible. Illicit fentanyl was flooding the streets, and officers had limited information. Later, medical experts, including the American College of Medical Toxicology and the American Academy of Clinical Toxicology clarified that incidental exposure leading to overdose is extremely unlikely. Other countries adjusted their guidance accordingly. Special Episode. The Law Enforcement Talk Radio Show and Podcast episode is available for free on their website , Apple Podcasts , Spotify and most major podcast platforms. But misinformation lingers, and it carries consequences. Officers who believe they've been exposed can experience panic attacks, hyperventilation, vertigo, and racing heart rates. These symptoms are real and distressing, yet often misinterpreted as fentanyl toxicity. In a culture where fear is seen as weakness, these events can go under-reported or misdiagnosed, potentially leading to delayed or inappropriate medical care. We stand by this critical point: Accidental fentanyl exposure can have drastic effects when combined with preexisting health conditions, particularly involving the heart. These incidents deserve serious, compassionate, and accurate medical evaluation. Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. The special episode can be found on The Law Enforcement Talk Radio Show and Podcast website, on Apple podcasts, Spotify, Youtube and on LinkedIn, Facebook, Instagram, and across most podcast platforms where listeners will find authentic law enforcement stories. The FDA Warning: When Fentanyl Exposure Is Truly Deadly While incidental exposure myths persist among adults, there is one area where the danger is undisputed. The FDA warns that accidental exposure to fentanyl patches continues to be deadly to children. Fentanyl patches are prescribed for opioid-tolerant patients and release fentanyl through the skin over several days. Tragically, children have died after: Putting used or unused patches in their mouths Sticking patches onto their skin Even used patches can contain enough fentanyl to be fatal. The FDA urges caregivers to: Store patches securely Dispose of them properly Keep naloxone readily available If a child is suspected of exposure, call 911 immediately. Trauma, PTSD, and the Cost of Service Jeff's story highlights a truth many don't want to face: trauma doesn't end when the sirens stop. First responders routinely carry: Cumulative stress Psychological trauma PTSD Chronic health problems These issues affect not only their careers but their families, hobbies, and identities. For many even the simple joys of fishing and hunting, once outlets for peace, were impacted by his injuries and recovery. Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. The full podcast episode is streaming now on their website, on Apple Podcasts, Spotify, Youtube and across Facebook, Instagram, and LinkedIn. Turning Pain Into Purpose: Hometown Heroes Alliance Instead of walking away, Jeff chose to give back. He now dedicates his time to Hometown Heroes Alliance, a nonprofit organization that supports wounded, injured, and disabled first responders, those who are often left financially and emotionally vulnerable after serving their communities. Hometown Heroes Alliance focuses on: Raising awareness for injured first responders Providing financial, physical, and emotional support Hosting benefit events, including concerts Producing brand-funded television and digital media to amplify impact From hurricane-stricken areas in Florida and Texas to less-publicized tragedies across the country, the organization helps heroes who lost homes, suffered disabling injuries, or sacrificed everything while protecting others. Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. On the Law Enforcement Talk Radio Show and Podcast website on Apple Podcasts, Spotify, Youtube, Facebook, Instagram, LinkedIn, and most major podcast platforms. As long as there are heroes answering the call, there will be a need for compassion—and action. A Story That Needs to Be Heard Jeff Brown's journey is more than a headline. It's a reminder that behind every badge is a human being who absorbs trauma so others don't have to. This story belongs on every platform, Facebook, Instagram, YouTube, Apple, Spotify, and Podcast networks, because awareness saves lives, corrects misinformation, and honors those who continue to serve, even after the job nearly takes everything from them. He survived fentanyl exposure. He lives with the injuries. And he refuses to stop fighting for his fellow heroes. Find a wide variety of great podcasts online at The Podcast Zone Facebook Page , look for the one with the bright green logo. Be sure to check out our website . Be sure to follow us on X , Instagram , Facebook, Pinterest, Linkedin and other social media platforms for the latest episodes and news. Listeners can tune in on the Law Enforcement Talk Radio Show website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform and follow updates on Facebook, Instagram, and other major News outlets. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Background song Hurricane is used with permission from the band Dark Horse Flyer. You can contact John J. “Jay” Wiley by email at Jay@letradio.com , or learn more about him on their website . Stay connected with updates and future episodes by following the show on Facebook, Instagram, LinkedIn, their website and other Social Media Platforms. Interested in being a guest, sponsorship or advertising opportunities send an email to the host and producer of the show jay@letradio.com. Listen to this special episode on the Law Enforcement Talk Radio Show and Podcast website on Apple Podcasts, Spotify, Youtube, Facebook, Instagram, LinkedIn, and most major podcast platforms. Did Fentanyl Almost Kill a Cop? One Deputy's Story of Trauma, Survival, and a Mission to Help Others. Special Episode. Attributions NIH FDA.gov Hometown Heroes Alliance   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

New laws were enacted in 2025 that will affect California trusts and estates practitioners on January 1, 2026. Join our three speakers, attorneys Kristin Yokomoto, Paul Gruwell, and Mara Mahana, on this episode as they summarize the highlights of the new laws and how they affect estate planning, trust administration, incapacity, litigation, and more. Look for an in-depth article on the new laws in an upcoming issue of the Trusts & Estates Quarterly.About Our Podcast Panel: Kristin Yokomoto is a partner at Baker & Hostetler LLP in the Orange County office. She practices in the areas of estate planning for high net worth clients, trust administration, probate, and fiduciary litigation. Kristin is a Member of the California Lawyers Association Trusts and Estates Executive Committee (TEXCOM) and The American College of Trust and Estate Counsel (ACTEC). She is a Legal Specialist in Estate Planning, Trust & Probate Law certified by the State Bar of California Paul Gruwell is a civil litigation partner of Ragghianti Freitas LLP in San Rafeal.  He specializes in Trust and Estate Litigation and represents individuals, families, fiduciaries, and charitable organizations in all phases of disputes, including through contested evidentiary hearings, trials, and appeals. His practice in this area spans trust and will contests, fiduciary breach of duty, removal of trustees and executors, accounting disputes, probate disputes, surcharge actions, and fee disputes. Paul is a Member of TEXCOM. Mara Mahana is a Wealth Strategist and Senior Director at Syon Capital LLC in San Francisco and formerly a practicing attorney for 20 years in the field of trusts and estates law working with high- and ultra-high net worth clients to review, develop, and consult on estate and wealth transfer plans, taking into consideration clients' unique values, needs and circumstances. Mara is a Member of TEXCOM.Thank you for listening to Trust Me!Trust Me is Produced by Foley Marra StudiosEdited by Cat Hammons and Todd Gajdusek

Dr. DebWhat if I told you that the stomach acid medication you’re taking for heartburn is actually causing the problem it’s supposed to solve that your doctor learned virtually nothing about nutrition, despite spending 8 years in medical school. That the very system claiming to heal you was deliberately designed over a hundred years ago by an oil tycoon, John D. Rockefeller, to create lifelong customers, not healthy people. Last week a patient spent thousands of dollars on tests and treatments for acid reflux, only to discover she needed more stomach acid, not less. The medication keeping her sick was designed to do exactly that. Today we’re exposing the greatest medical deception in modern history, how a petroleum empire systematically destroyed natural healing wisdom turned medicine into a profit machine. And why the treatments, keeping millions sick were engineered that way from the beginning. This isn’t about conspiracy theories. This is a documented history that explains why you feel so lost about your own body’s needs welcome back to let’s talk wellness. Now the show where we uncover the root causes of chronic illness, explore cutting edge regenerative medicine, and empower you with the tools to heal. I’m Dr. Deb. And today we’re diving into how the Rockefeller Medical Empire systematically destroyed natural healing wisdom and replaced it with profit driven systems that keeps you dependent on treatments instead of achieving true health. If you or someone you love has been running to the doctor for every minor ailment, taking acid blockers that seem to make digestive problems worse, or feeling confused about basic body functions that our ancestors understood instinctively. This episode is for you. So, as usual, grab a cup of coffee, tea, or whatever helps you unwind. Settle in and let’s get started on your journey to reclaiming your health sovereignty all right. So here we are talking about the Rockefeller Medical Revolution. Now, what if your symptoms aren’t true diagnosis, but rather the predictable result of a medical system designed over a hundred years ago to create lifelong customers instead of healthy people. Now I learned this when I was in naturopathic school over 20 years ago. And it hasn’t been talked about a lot until recently. Recently. People are exposing the truth about what actually happened in our medical system. And today I want to take you back to the early 19 hundreds to understand how we lost the basic health wisdom that sustained humanity for thousands of years. Yes, I said that thousands of years. This isn’t conspiracy theory. This is documented history. That explains why you feel so lost when it comes to your own body’s needs. You know by the turn of the 20th century. According to meridian health Clinic’s documentation. Rockefeller controlled 90% of all petroleum refineries in America and through ownership of the Standard Oil Corporation. But Rockefeller saw an opportunity that went far beyond oil. He recognized that petrochemicals could be the foundation for a completely new medical system. And here’s what most people don’t know. Natural and herbal medicines were very popular in America during the early 19 hundreds. According to Staywell, Copper’s historical analysis, almost one half of medical colleges and doctors in America were practicing holistic medicine, using extensive knowledge from Europe and native American traditions. People understood that food was medicine, that the body had natural healing mechanisms, and that supporting these mechanisms was the key to health. But there was a problem with the Rockefeller’s business plan. Natural medicines couldn’t be patented. They couldn’t make a lot of money off of them, because they couldn’t hold a patent. Petrochemicals, however, could be patented, could be owned, and could be sold for high profits. So Rockefeller and Andrew Carnegie devised a systematic plan to eliminate natural medicine and replace it with petrochemical based pharmaceuticals and according to E. Richard Brown’s comprehensive academic documentation in Rockefeller, medicine men. Medicine, and capitalism in America. They employed the services of Abraham Flexner, who proceeded to visit and assess every single medical school in us and in Canada. Within a very short time of this development, medical schools all around the us began to collapse or consolidate. The numbers are staggering. By 1910 30 schools had merged, and 21 had closed their doors of the 166 medical colleges operating in 19 0, 4, a hundred 33 had survived by 1910 and a hundred 4 by 1915, 15 years later, only 76 schools of medicine existed in the Us. And they all followed the same curriculum. This wasn’t just about changing medical education. According to Staywell’s copper historical analysis. Rockefeller and Carnegie influenced insurance companies to stop covering holistic treatments. Medical professionals were trained in the new pharmaceutical model and natural solutions became outdated or forgotten. Not only that alternative healthcare practitioners who wanted to stay practicing in alternative medicine were imprisoned for doing so as documented by the potency number 710. The goal was clear, create a system where scientists would study how plants cure disease, identify which chemicals in the plants were effective and then recreate a similar but not identical chemical in the laboratory that would be patented. E. Richard Brown’s documents. The story of how a powerful professional elite gained virtual homogeny in the western theater of healing by effectively taking control of the ethos and practice of Western medicine. The result, according to the healthcare spending data, the United States now spends 17.6% of its Gdp on health care 4.9 trillion dollars in 2023, or 14,570 per person nearly twice as much as the average Oecd country. But it doesn’t focus on cure. But on symptoms, and thus creating recurring clients. This systematic destruction of natural medicine explains why today’s healthcare providers often seem baffled by simple questions about nutrition why they immediately reach for a prescription medication for minor ailments, and why so many people feel disconnected from their own body’s wisdom. We’ve been trained over 4 generations to believe that our bodies are broken, and that symptoms are diseases rather than messages, and that external interventions are always superior to supporting natural healing processes. But here’s what they couldn’t eliminate your body’s innate wisdom. Your digestive system still functions the same way it did a hundred years ago. Your immune system still follows the same patterns. The principles of nutrition, movement and stress management haven’t changed. We’ve just forgotten how to listen and respond. We’re gonna take a small break here and hear from our sponsor. When we come back. We’re gonna talk about the acid reflux deception, and why your cure is making you sicker, so don’t go away all right, welcome back. So I want to give you a perfect example of how Rockefeller medicine has turned natural body wisdom upside down, the treatment of acid, reflux, and heartburn. Every single day in my practice I see patients who’ve been taking acid blocker medications, proton pump inhibitors like prilosec nexium or prevacid for years, not for weeks, years, and sometimes even decades. They come to me because their digestive problems are getting worse, not better. They have bloating and gas and nutrition deficiencies. And we’re seeing many more increased food sensitivities. And here’s what’s happening in the Us. Most people often attribute their digestive problems to too much stomach acid. And they use medications to suppress the stomach acid, but, in fact symptoms of chronic acid, reflux, heartburn, or gerd, can also be caused by too little stomach acid, a condition called hyper. Sorry hypochlorhydria normal stomach acid has a Ph level of one to 2, which is highly acidic. Hydrochloric acid plays an important role in your digestion and your immunity. It helps to break down proteins and absorb essential nutrients, and it helps control viruses and bacteria that might otherwise infect your stomach. But here’s the crucial part that most people don’t understand, and, according to Cleveland clinic, your stomach secretes lower amounts of hydrochloric acid. As you age. Hypochlorhydria is more common in people over the age of 40, and even more common over the age of 65. Webmd states that the stomach acid can produce less acid as a result of aging and being 65 or older is a risk factor for developing hypochlorhydria. We’ve been treating this in my practice for a long time. It’s 1 of the main foundations that we learn as naturopathic practitioners and as naturopathic doctors, and there are times where people need these medications, but they were designed to be used short term not long term in a 2,013 review published in Medical News today, they found that hypochlorhydria is the main change in the stomach acid of older adults. and when you have hypochlorydria, poor digestion from the lack of stomach, acid can create gas bubbles that rise into your esophagus or throat, carrying stomach acid with them. You experience heartburn and assume that you have too much acid. So you take acid blockers which makes the underlying problem worse. Now, here’s something that will shock you. PPI’s protein pump inhibitors were originally studied and approved by the FDA for short-term use only according to research published in us pharmacists, most cases of peptic ulcers resolve in 6 to 8 weeks with PPI therapy, which is what these medications were created for. Originally the American family physician reports that for erosive esophagitis. Omeprazole is indicated for short term 4 to 8 weeks. That’s it. Treatment and healing and done if needed. An additional 4 to 8 weeks of therapy may be considered and the University of Minnesota College of Pharmacy, States. Guidelines recommended a treatment duration of 8 weeks with standard once a day dosing for a PPI for Gerd. The Canadian family physician, published guidelines where a team of healthcare professionals recommended prescribing Ppis in adults who suffer from heartburn and who have completed a minimum treatment of 4 weeks in which symptoms were relieved. Yet people are taking these medications for years, even decades far beyond their intended duration of use and a study published in Pmc. Found that the threshold for defining long-term PPI use varied from 2 weeks to 7 years of PPI use. But the most common definition was greater than one year or 6 months, according to the research in clinical context, use of Ppis for more than 8 weeks could be reasonably defined as long-term use. Now let’s talk about what these acid blocker medications are actually doing to your body when used. Long term. The research on long term PPI use is absolutely alarming. According to the comprehensive review published in pubmed central Pmc. Long-term use of ppis have been associated with serious adverse effects, including kidney disease, cardiovascular disease fractures because you’re not absorbing your nutrients, and you’re being depleted. Infections, including C. Diff pneumonia, micronutrient deficiencies and hypomagnesium a low level of magnesium anemia, vitamin, b, deficiency, hypocalcemia, low calcium, low potassium. and even cancers, including gastric cancer, pancreatic cancer, colorectal cancer. And hepatic cancer and we are seeing all of these cancers on a rise, and we are now linking them back to some of these medications. Mayo clinic proceedings published research showing that recent studies regarding long-term use of PPI medication have noted potential adverse effects, including risks of fracture, pneumonia, C diff, which is a diarrhea. It’s a bacteria, low magnesium, low b 12 chronic kidney disease and even dementia. And a 2024 study published in nature communications, analyzing over 2 million participants from 5 cohorts found that PPI use correlated with increased risk of 15 leading global diseases, such as ischemic heart disease. Diabetes, respiratory infections, chronic kidney disease. And these associations showed dose response relationships and consistency across different PPI types. Now think about this. You take a medication for heartburn that was designed for 4 to 8 weeks of use, and when used long term, it actually increases your risk of life, threatening infections, kidney disease, and dementia. This is the predictable result of suppressing a natural body function that exists for important reasons. Hci plays a key role in many physiological processes. It triggers, intestinal hormones, prepares folate and B 12 for absorption, and it’s essential for absorption of minerals, including calcium, magnesium, potassium, zinc, and iron. And when you block acid production, you create a cascade of nutritional deficiencies and immune system problems that often manifest as seemingly unrelated health issues. So what’s the natural approach? Instead of suppressing stomach acid, we need to support healthy acid production and address the root cause of reflux healthcare. Providers may prescribe hcl supplements like betaine, hydrochloric acid. Bhcl is what it’s called. Sometimes it’s called betaine it’s often combined with enzymes like pepsin or amylase or lipase, and it’s used to treat hydrochloric acid deficiency, hypochlorhydria. These supplements can help your digestion and sometimes help your stomach acid gradually return back to normal levels where you may not need to use them all the time. Simple strategies include consuming protein at the beginning of the meal to stimulate Hcl production, consume fluids separately at least 30 min away from meals, if you can, and address the underlying cause like chronic stress and H. Pylori infections. This is such a sore subject for me. So many people walk around with an H. Pylori infection. It’s a bacterial infection in the stomach that can cause stomach ulcers, causes a lot of stomach pain and burning. and nobody is treating the infection. It’s a bacterial infection. We don’t treat this anymore with antibiotics or antimicrobials. We treat it with Ppis. But, Ppis don’t fix the problem. You have to get rid of the bacteria once the bacteria is gone, the gut lining can heal. Now it is a common bacteria. It can reoccur quite frequently. It’s highly contagious, so you can pick it up from other people, and it may need multiple courses of treatment over a person’s lifetime. But you’re actually treating the problem. You’re getting rid of the bacteria that’s creating the issue instead of suppressing the acid. That’s not fixing the bacteria which then leads to a whole host of other problems that we just talked about. There are natural approaches to increase stomach acid, including addressing zinc deficiency. And since the stomach uses zinc to produce Hcl. Taking probiotics to help support healthy gut bacteria and using digestive bitters before meals can be really helpful. This is exactly what I mean about reclaiming the body’s wisdom. Instead of suppressing natural functions, we support them instead of creating drug dependency, we restore normal physiology. Instead of treating symptoms indefinitely, we address the root cause and help the body heal itself. In many cultures. Bitters is a common thing to use before or after a meal. But yet in the American culture we don’t do that anymore. We’ve not passed on that tradition. So very few people understand how to use bitters, or what bitters are, or why they’re important. And these basic things that can be used in your food and cooking and taking could replace thousands of dollars of medication that you don’t really need. That can create many more problems along the way. Now, why does your doctor know nothing about nutrition. Well, I want to address something that might shock you all. The reason your doctor seems baffled when you ask about nutrition isn’t because they’re not intelligent. It’s because they literally never learned this in medical school statistics on nutritional education in medical schools are staggering and help explain why we have such a health literacy crisis in America. According to recent research published in multiple academic journals, only 27% of Us. Medical schools actually offer students. The recommended 25 h of nutritional training across 4 years of medical school. That means 73% of the medical schools don’t even meet the minimum standards set in 1985. But wait, it gets worse. A 2021 survey of medical schools in the Us. And the Uk. Found that most students receive an average of only 11 h of nutritional training throughout their entire medical program. and another recent study showed that in 2023 a survey of more than a thousand Us. Medical students. About 58% of these respondents said they received no formal nutritional education while in medical school. For 4 years those who did averaged only 3 h. I’m going to say this again because it’s it’s huge 3 h of nutritional education per year. So let me put this in perspective during 4 years of medical school most students spend fewer than 20 h on nutrition that’s completely disproportionate to its health benefits for patients to compare. They’ll spend hundreds of hours learning about pharmaceutical interventions, but virtually no time learning how food affects health and disease. Now, could this be? Why, when we talk about nutrition to lower cholesterol levels or control your diabetes, they blow you off, and they don’t answer you. It’s because they don’t understand. But yet what they’ll say is, people won’t change their diet. That’s why you have to take medication. That’s not true. I will tell you. I work with people every single day who are willing to change their diet. They’re just confused by all the information that’s out there today about nutrition. And what diet is the right diet to follow? Do I do, Paleo? Do I do? Aip? Do I do carnivore? Do I do, Keto? Do I do? Low carb? There’s so many diets out there today? It’s confusing people. So I digress. But let’s go back. So here’s the kicker. The limited time medical students do spend on nutrition office often focuses on nutrients think proteins and carbohydrates rather than training in topics such as motivational interviewing or meal planning, and as one Stanford researcher noted, we physicians often sound like chemists rather than counselors who can speak with patients about diet. Isn’t that true? We can speak super high level up here, but we can’t talk basics about nutrition. And this explains why only 14% of the physicians believe they were adequately trained in nutritional counseling. Once they entered practice and without foundational concepts of nutrition in undergrad work. Graduate medical education unsurprisingly falls short of meeting patients, needs for nutritional guidance in clinical practice, and meanwhile diet, sensitive chronic diseases continue to escalate. Although they are largely preventable and treatable by nutritional therapies and dietary. Lifestyle changes. Now think about this. Diet. Related diseases are the number one cause of death in the Us. The number one cause. Yet many doctors receive little to no nutritional education in medical school, and according to current health statistics from 2017 to march of 2020. Obesity prevalence was 19.7% among us children and adolescents affecting approximately 14.7 million young people. About 352,000 Americans, under the age of 20, have been diagnosed with diabetes. Let me say this again, because these numbers are astounding to me. 352,000 Americans, under the age of 20, have been diagnosed with diabetes with 5,300 youth diagnosed with type, 2 diabetes annually. Yet the very professionals we turn to for health. Guidance were never taught how food affects these conditions and what drug has come to the rescue Glp. One S. Ozempic wegovy. They’re great for weight loss. They’re great for treating diabetes. But why are they here? Well, these numbers are. Why, they’re here. This is staggering to put 352,000 Americans under the age of 20 on a glp, one that they’re going to be on for the rest of their lives at a minimum of $1,200 per month. All we have to do is do the math, you guys, and we can see exactly what’s happening to our country, and who is getting rich, and who is getting the short end of the stick. You’ve become a moneymaker to the pharmaceutical industry because nobody has taught you how to eat properly, how to live, how to have a healthy lifestyle, and how to prevent disease, or how to actually reverse type 2 diabetes, because it’s reversible in many cases, especially young people. And we do none of that. All we do is prescribe medications. Metformin. Glp, one for the rest of your life from 20 years old to 75, or 80, you’re going to be taking medications that are making the pharmaceutical companies more wealth and creating a disease on top of a disease on top of a disease. These deficiencies in nutritional education happen at all levels of medical training, and there’s been little improvement, despite decades of calls for reform. In 1985, the National Academy of Sciences report that they recommended at least 25 h of nutritional education in medical school. But a 2015 study showed only 29% of medical schools met this goal, and a 2023 study suggests the problem has become even worse. Only 7.8% of medical students reported 20 or more hours of nutritional education across all 4 years of medical school. This systemic lack of nutrition, nutritional education has been attributed to several factors a dearth of qualified instructors for nutritional courses, since most physicians do not understand nutrition well enough to teach it competition for curriculum time, with schools focusing on pharmaceutical interventions rather than lifestyle medicine and a lack of external incentives that support schools, teaching nutrition. And ironically, many medical schools are part of universities that have nutrition departments with Phd. Trained professors who could fill this gap by teaching nutrition in medical schools but those classes are often taught by physicians who may not have adequate nutritional training themselves. This explains so much about what I see in my practice. Patients come to me confused and frustrated because their primary care doctors can’t answer basic questions about how food affects their health conditions. And these doctors aren’t incompetent. They simply were never taught this information. And the result is that these physicians graduate, knowing how to prescribe medications for diabetes, but not how dietary changes can prevent or reverse it. They can treat high blood pressure with pharmaceuticals, but they may not know that specific nutritional approaches can be equally or more effective. This isn’t the doctor’s fault. It’s the predictable result of medical education systems that was deliberately designed to focus on patentable treatments rather than natural healing approaches. And remember this traces back to the Rockefeller influence on medical education. You can’t patent an apple or a vegetable. But you can patent a drug now. Why can’t we trust most medical studies? Well this just gets even better. I need to address something that’s crucial for you to understand as you navigate health information. Why so much of the medical research you hear about in the news is biased, and why peer Review isn’t the gold standard of truth you’ve been told it is. The corruption in medical research by pharmaceutical companies is not a conspiracy theory. It’s well documented scientific fact, according to research, published in frontiers, in research, metrics and analytics. When pharmaceutical and other companies sponsor research, there is a bias. A systematic tendency towards results serving their interests. But the bias is not seen in the formal factors routinely associated with low quality science. A Cochrane Review analyzed 75 studies of the association between industry, funding, and trial results, and these authors concluded that trials funded by a drug or device company were more likely to have positive conclusions and statistically significant results, and that this association could not be explained by differences in risk of bias between industry and non-industry funded trials. So think about that. According to the Cochrane collaboration, industry funding itself should be considered a standard risk of bias, a factor in clinical trials. Studies published in science and engineering ethics show that industry supported research is much more likely to yield positive outcomes than research with any other sponsorship. And here’s how the bias gets introduced through choice of compartor agents, multiple publications of positive trials and non-publication of negative trials reinterpreting data submitted to regulatory agencies, discordance between results and conclusions, conflict of interest leading to more positive conclusions, ghostwriting and the use of seating trials. Research, published in the American Journal of Medicine. Found that a result favorable to drug study was reported by all industry, supported studies compared with two-thirds of studies, not industry, supported all industry, supported studies showed favorable results. That’s not science that’s marketing, masquerading as research. And according to research, published in sciencedirect the peer review system which we’re told ensures quality. Science has a major limitation. It has proved to be unable to deal with conflicts of interest, especially in big science contexts where prestigious scientists may have similar biases and conflicts of interest are widely shared among peer reviewers. Even government funded research can have conflicts of interest. Research published in pubmed States that there are significant benefits to authors and investigators in participating in government funded research and to journals in publishing it, which creates potentially biased information that are rarely acknowledged. And, according to research, published in frontiers in research, metrics, and analytics, the pharmaceutical industry has essentially co-opted medical knowledge systems for their particular interests. Using its very substantial resources. Pharmaceutical companies take their own research and smoothly integrate it into medical science. Taking advantage of the legitimacy of medical institutions. And this corruption means that much of what passes for medical science is actually influenced by commercial interests rather than pursuant of truth. Research published in Pmc. Shows that industry funding affects the results of clinical trials in predictable directions, serving the interests of the funders rather than the patients. So where can we get this reliable, unbiased Health information, because this is critically important, because your health decisions should be based on the best available evidence, not marketing disguised as science. And so here are some sources that I recommend for trustworthy health and nutritional information. They’re independent academic sources. According to Harvard Chan School of public health their nutritional, sourced, implicitly states their content is free from industry, influence, or support. The Linus Pauling Institute, Micronutrient Information Center at Oregon State University, which, according to the Glendale Community college Research Guide provides scientifically accurate information about vitamins, minerals, and other dietary factors. This Institute has been around for decades. I’ve used it a lot. I’ve gotten a lot of great information from them. Very, very trustworthy. According to the Glendale Community College of Nutrition Resource guide Tufts, University of Human Nutritional Research Center on aging is one of 6 human nutrition research centers supported by the United States Department of Agriculture, the Usda. Their peer reviewed journals with strong editorial independence though you must still check funding resources. And how do you evaluate this information? Online? Well, according to medlineplus and various health literacy guides when evaluating health information medical schools and large professional or nonprofit organizations are generally reliable sources, but remember, it is tainted by the Rockefeller method. So, for example, the American College of cardiology. Excuse me. Professional organization and the American Heart Institute a nonprofit are both reliable sources. Sorry about that of information on heart health and watch out for ads designed to look like neutral health information. If the site is funded by ads they should be clearly marked as advertisements. Excuse me, I guess I’m talking just a little too much now. So when the fear of medicine becomes deadly. Now, I want to address something critically important that often gets lost in conversations about health, sovereignty, and questioning the medical establishment. And while I’ve spent most of this episode explaining how the Rockefeller medical system has created dependency and suppressed natural healing wisdom. There’s a dangerous pendulum swing happening that I see in my practice. People becoming so fearful of pharmaceutical interventions that they refuse lifesaving treatments when they’re genuinely needed. This is where balance and clinical judgment become absolutely essential. Yes, we need to reclaim our basic health literacy and reduce our dependency on unnecessary medical interventions. But there are serious bacterial infections that require immediate antibiotic treatment, and the consequences of avoiding treatment can be devastating or even fatal. So let me share some examples from research that illustrate when antibiotic fear becomes dangerous. Let’s talk about Lyme disease, and when natural approaches might not be enough. The International Lyme Disease Association ilads has conducted extensive research on chronic lyme disease, and their findings are sobering. Ileds defines chronic lyme disease as a multi-system illness that results from an active and ongoing infection of pathogenic members of the Borrelia Brdorferi complex. And, according to ilads research published in their treatment guidelines, the consequences of untreated persistent lyme infection far outweigh the potential consequences of long-term antibiotic therapy in well-designed trials of antibiotic retreatment in patients with severe fatigue, 64% in the treatment arm obtained clinically significant and sustained benefit from additional antibiotic therapy. Ilas emphasizes that cases of chronic borrelia require individualized treatment plans, and when necessary antibiotic therapy should be extended their research demonstrates that 20 days of prophylactic antibiotic treatment may be highly effective for preventing the onset of lyme disease. After known tick bites and patients with early Lyme disease may be best served by receiving 4 to 6 weeks of antibiotic therapy. Research published in Pmc. Shows that patients with untreated infections may go on to develop chronic, debilitating, multisystem illnesses that is difficult to manage, and numerous studies have documented persistent Borrelia, burgdorferi infection in patients with persistent symptoms of neurological lyme disease following short course. Antibiotic treatment and animal models have demonstrated that short course. Antibiotic therapy may fail to eradicate lyme spirochetes short course is a 1 day. One pill treatment of doxycycline. Or less than 20 days of antibiotics, is considered a short course. It’s not long enough to kill the bacteria. The bacteria’s life cycle is about 21 days, so if you don’t treat the infection long enough, the likelihood of that infection returning is significant. They’ve also done studies in the petri dish, where they show doxycycline being put into a petri dish with active lyme and doxycycline does not kill the infection, it just slows the replication of it. Therefore, using only doxycycline, which is common practice in lyme disease may not completely eradicate that infection for you. So let’s talk about another life threatening emergency. C. Diff clostridia difficile infection, which represents another example where antibiotic treatment is absolutely essential, despite the fact that C diff itself is often triggered by antibiotic use. According to Cleveland clinic C. Diff is estimated to cause almost half a million infections in the United States each year, with 500,000 infections, causing 15,000 deaths each year. Studies reported by Pmc. Found thirty-day Cdi. Mortality rates ranging from 6 to 11% and hospitalized Cdi patients have significantly increased the risk of mortality and complications. Research published in Pmc shows that 16.5% of Cdi patients experience sepsis and that this increases with reoccurrences 27.3% of patients with their 1st reoccurrence experience sepsis. While 33.1% with 2 reoccurrences and 43.2% with 3 or more reoccurrences. Mortality associated with sepsis is very high within hospital 30 days and 12 month mortality rates of 24%, 30% and 58% respectively. According to the Cdc treatment for C diff infection usually involves taking a specific antibiotic, such as vancomycin for at least 10 days, and while this seems counterintuitive, treating an antibiotic associated infection with more antibiotics. It’s often lifesaving. Now let’s talk about preventing devastating complications. Strep throat infections. Provide perhaps the clearest example of when antibiotic treatment prevents serious long-term consequences, and, according to Mayo clinic, if untreated strep throat can cause complications such as kidney inflammation and rheumatic fever. Rheumatic fever can lead to painful and inflamed joints, and a specific type of rash of heart valve damage. We also know that strep can cause pans pandas, which is a systemic infection, often causing problems with severe Ocd. And anxiety and affecting mostly young people. The research is unambiguous. According to the Cleveland clinic. Rheumatic fever is a rare complication of untreated strep, throat, or scarlet fever that most commonly affects children and teens, and in severe cases it can lead to serious health problems that can affect your child’s heart. Joints and organs. And research also shows that the rate of development of rheumatic fever in individuals with untreated strep infections is estimated to be 3%. The incidence of reoccurrence with a subsequent untreated infection is substantially greater. About 50% the rate of development is far lower in individuals who have received antibiotic treatment. And according to the World health organization, rheumatic heart disease results from the inflammation and scarring of the heart valves caused by rheumatic fever, and if rheumatic fever is not treated promptly, rheumatic heart disease may occur, and rheumatic heart disease weakens the valves between the chambers of the heart, and severe rheumatic heart disease can require heart surgery and result in death. The who states that rheumatic heart disease remains the leading cause of maternal cardiac complications during pregnancy. And additionally, according to the National Kidney foundation. After your child has either had throat or skin strep infection, they can develop post strep glomerial nephritis. The Strep bacteria travels to the kidneys and makes the filtering units of the kidneys inflamed, causing the kidneys to be able to unable or less able to fill and filter urine. This can develop one to 2 weeks after an untreated throat infection, or 3 to 4 weeks after an untreated skin infection. We need to find balance. And here’s what I want you to understand. Questioning the medical establishment and developing health literacy doesn’t mean rejecting all medical interventions. It means developing the wisdom to know when they’re necessary and lifesaving versus when they’re unnecessary and potentially harmful. When I see patients with confirmed lyme disease, serious strep infections or life. Threatening conditions like C diff. I don’t hesitate to recommend appropriate therapy but I also work to support their overall health address, root causes, protect and restore their gut microbiome and help them recover their natural resilience. The goal isn’t to avoid all medical interventions. It’s to use them wisely when truly needed, while simultaneously supporting your body’s inherent healing capacity and addressing the lifestyle factors that created the vulnerability. In the 1st place. All of this can be extremely overwhelming, and it can be frightening to understand or learn. But remember, the power that you have is knowledge. The more you learn about what’s actually happening in your health, in understanding nutrition. in learning what your body wants to be fed, and how it feels, and working with practitioners who are holistic in nature, natural, integrative, functional, whatever we want to call that these days. The more you can learn from them, the more control you have over your own health and what I would urge you to do is to teach your children what you’re learning. Teach them how to live a healthy lifestyle, teach them how to keep a clean environment. This is how we take back our own health. So thank you for joining me today on, let’s talk wellness. Now, if this episode resonated with you. Please share it with someone who could benefit from understanding how the Rockefeller medical system has shaped our approach to health, and how to reclaim your body’s wisdom while using medical care appropriately when truly needed. Remember, wellness isn’t just about feeling good. It’s about understanding your body, trusting its wisdom, supporting its natural healing capacity, and knowing when to seek appropriate medical intervention. If you’re ready to explore how functional medicine can help you develop this deeper health knowledge while addressing root causes rather than just managing symptoms. You can get more information from serenityhealthcarecenter.com, or reach out directly to us through our social media channels until next time. I’m Dr. Dab, reminding you that your body is your wisest teacher. Learn to listen, trust the process, use medical care wisely when needed, and take care of your body, mind, and spirit. Be well, and we’ll see you on the next episode.The post Episode 250 -The Great Medical Deception first appeared on Let's Talk Wellness Now.

The Trump Administration ordered universities to turn over data to prove they're not considering race in admissions. But education expert Richard Kahlenberg argues that for college admissions to look at merit fairly, they need to look at class. *** Thank you for listening. Help power On Point by making a donation here: www.wbur.org/giveonpoint

Strap in and grab your NG tubes, because the EGS team in TIGER Country is taking you on a fast, forceful, and evidence-packed ride through 15 years of global SBO literature. From the OG 2011 Zielinski model to the latest 2025 predictive tools sweeping across Europe and North America, we're breaking down what matters when the bowel stops behaving and the clock starts ticking.  Join Dr. Rushabh Dev and the Acute Care Surgery crew at the University of Missouri as they tackle the most common EGS consult in America with humor, data, and real-world pearls. Get ready for CT red flags, strangulation scores, Gastrografin truths, and the eternal battle between “operate early” vs. “wait it out.” Whether you're a med student trying to decode your first CT or a seasoned attending debating the next Gastrografin challenge, this episode delivers the insights you need to Dominate the Day. Participants: Dr. Rushabh Dev FACS (Moderator, Surgical Attending) – Assistant Professor of Surgery, Associate PD ACS & SCCM Fellowship, SICU Medical Director, Lieutenant Commander United States Navy Reserve   Dr. Raymond Okeke; Acute Care Surgery & SCCM Fellow  Dr. Eugene Ismailov, General Surgery Resident; PGY 5 Dr. Brycen Ratcliffe, General Surgery Resident; PGY 4 Dr. Desra Flecher, General Surgery Resident; PGY 3 Objectives: 1. Identify the core clinical and CT predictors of operative need in SBO including mesenteric edema, free fluid, closed-loop obstruction, lack of enhancement, and feces sign absence — and understand how these features have remained consistent across 15 years of research. 2. Compare major international SBO predictive models (Zielinski, Geneva Severity Score, STRISK, and NOFA) and describe how they inform real-time decision-making in North American acute care surgery. 3. Apply evidence-based algorithms, including the 2025 JTACS EGS pathway to structure SBO evaluation, integrate Water-Soluble Contrast studies, and avoid delayed surgery in high-risk patients. 4. Evaluate the long-term impact of operative vs. non-operative management with emphasis on recurrence risk, timing between episodes, and how to incorporate recurrence data into patient counseling. 5. Synthesize 15 years of evolving SBO literature into practical bedside strategies by balancing red-flag findings, risk-model guidance, and individualized clinical judgment to optimize outcomes. STRISK and NOFA Calculator: Prediction Models | Clinical Abdominal Surgery Helsinki References  1. Geneva Clinical Severity Score Wassmer, C. H., Guber, J., Zeindler, J., Meier, R. P. H., Ouaïssi, M., Ris, F., Morel, P., Didier, C., & Gkikas, I. (2023). A new clinical severity score for the management of adhesive small bowel obstruction: A cohort study. International Journal of Surgery, 109, 262–270. https://pubmed.ncbi.nlm.nih.gov/37026805/ 2. STRISK & NOFA Predictive Models Räty, S., Rinta-Kilpinen, E., Eklund, M., Turunen, N., Koskinen, I., Rasilainen, S., Korhonen, T., & Paajanen, H. (2025). Development and external validation of prediction risk models for strangulation or non-operative treatment failure in small bowel obstruction: A multicenter prospective study. Surgery, 178(1), 45–56. Prediction Models | Clinical Abdominal Surgery Helsinki 3. JTACS EGS Algorithm – Evidence-Based, Cost-Effective Management Livingston, D. H., Wolfson, D., Cogbill, T. H., Rice, T. W., Patel, N., et al. (2025). Evidence-based, cost-effective management of small bowel obstruction: An Emergency General Surgery Algorithms Work Group project. Journal of Trauma and Acute Care Surgery, 98(4), 512–528. https://pubmed.ncbi.nlm.nih.gov/40842046/ 4. Tennessee Recurrence Study (Operative vs Non-Operative Management) Medvecz, A. J., Dennis, B. M., Wang, L., Countouris, M. E., Croce, M. A., Sharpe, J. P., Ivanova, A., & Miller, R. S. (2020). Impact of operative management on recurrence of adhesive small bowel obstruction: A longitudinal analysis of a statewide database. Journal of the American College of Surgeons, 230(4), 544–551.e1. https://pubmed.ncbi.nlm.nih.gov/31954815/ 5. Early Predictive SBO Work – Zielinski (2010–2011) Zielinski, M. D., Eiken, P. W., Bannon, M. P., Heller, S. F., Lohse, C. M., & Huebner, M. (2010). Small bowel obstruction—Who needs an operation? A multivariate prediction model. World Journal of Surgery, 34(5), 910–919. https://pubmed.ncbi.nlm.nih.gov/20217412/ 6. Zielinski, M. D., Haddad, N. N., Cullinane, D. C., Eiken, P. W., & Huebner, M. (2011). Prospective, observational validation of a multivariate small bowel obstruction model to predict the need for operative intervention. Journal of the American College of Surgeons, 212(6), 1068–1076. https://pubmed.ncbi.nlm.nih.gov/21458305/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKevin Shea, PharmDPharmacist Vytal Options  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation.2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-25-377-H01-PInitial release date: 12/29/2025Expiration date: 12/29/2026Additional CPE details can be found here.

As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKevin Shea, PharmDPharmacist Vytal Options PRACTICE RESOURCEPurchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation.2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-25-377-H01-PInitial release date: 12/29/2025Expiration date: 12/29/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

360° Health Integrating Lifestyle Medicine into Your Workday Show Highlights It’s Your Life With Dr James JC Cooley and Co-Host Dr Michael Mantell- Rational Emotive & Cognitive Behavior Coach have a sit-down conversation with Dr. Richard Safeer -- Author, Speaker, Workplace HealthPioneer, and Thought Leader What is lifestyle medicine? How do I start or begin a lifestyle medicine approach? Why should we be thinking about lifestyle medicine during the workday? Many employers offer wellness programs. What is the difference between workplace wellness and lifestyle medicine? Dr. Richard Safeer Biography Richard Safeer, MD, earned his BS in Nutritional Biochemistry at Cornell University under the tutelage of T. Colin Campbell, author of the China Study, before attending medical school at State University of New York at Buffalo. Dr. Safeer is the Chief Medical Director of Employee Health and Well-being at Johns Hopkins Medicine, where he leads the Healthy at Hopkins employee health and well-being strategy. He also holds faculty appointments in the School of Medicine and Public Health at Johns Hopkins University. Prior to arriving at Hopkins, Dr. Safeer practiced family medicine in Northern Virginia. He was then on faculty at the George Washington University, serving as the Residency Director of Family Medicine in his last year at the institution. He was the Medical Director of an Occupational Health Center in Baltimore and Wellness Director for the Mid-Atlantic region of the parent company, just before starting at CareFirst BlueCross BlueShield in Baltimore, Maryland as the Medical Director of Preventive Medicine. He has been credited by some for bringing ‘wellness’ in to the realm of responsibilities of the managed care industry. He also led CareFirst BCBS to be among the first cohort of health plans to be accredited for Wellness by NCQA. He holds faculty appointments in both the Johns Hopkins School of Medicine as well as the School of Public Health. He continues to see patients one day a week in the Pediatric Cardiology department. Dr. Safeer is a fellow of the American Academy of Family Practice, The American College of Lifestyle Medicine, and the American College of Preventive Medicine. He served on the board of directors for the American College of Lifestyle Medicine. He is on the New England Journal of Medicine Catalyst Insight Council. Dr. Safeer has hiked and camped in the Andes, Alaska, Australia and across the Western United States. He lives in Columbia Maryland with his wife and three children, and their dog Kami. Website RichardSafeer.com A Cure for the Common Company: link https://amzn.to/3bG1q1D One great way to improve your health is to journal. Try, A Cure for the Common Workday Social Media https://www.linkedin.com/in/richardsafeer/ If you’re a leader and you want self-paced training to create a well-being culture on your team, go to creatingawellbeingculture.comSupport the show: http://www.cooleyfoundation.org/See omnystudio.com/listener for privacy information.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3236: Dr. Neal clears up the confusion around heart rate zones and fat loss, revealing that the often-cited “fat-burning zone” isn't a magic formula. He explains why variety, like combining resistance training with both low and high-intensity cardio, is key to improving fitness, preserving muscle, and boosting fat metabolism over time. Quotes to ponder: "Fat loss is a complicated process. There is no guarantee that working at a certain or target heart rate will lead to fat loss." "Mix up your workout routines. Incorporating variety into your workouts is probably the best thing to do." "Resistance training is the best way to make bigger muscles." Episode references: American College of Sports Medicine: https://www.acsm.org Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Robert McLean, former President of the American College of Physicians discusses the negative impact of the word provider, and encourages all physicians to take the 'No Provider Pledge.'PhysiciansForPatientProtection.org

In this solo podcast, I address the broader argument against aversive tools in dog training promoted by the AVSAB and the R+-only movement.Recently, Dr. Michael Bailey, President of the American Veterinary Medical Association, commented on the use of electronic collars in dog training. That comment triggered backlash and a strong response from Dr. Lisa Radosta, President of the American College of Veterinary Behaviorists.But this presentation is not about personalities.It's about the claim that aversives never have a place in dog training.Using peer-reviewed research, learning theory, and real-world outcomes, I examine whether the “no aversives ever” position is actually supported by evidence and what happens to dogs when ideology overrides results.At the end, I invite you, the trainers and owners, to share stories of dogs who are alive today because balanced training worked when nothing else did.Outcomes matter.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3236: Dr. Neal clears up the confusion around heart rate zones and fat loss, revealing that the often-cited “fat-burning zone” isn't a magic formula. He explains why variety, like combining resistance training with both low and high-intensity cardio, is key to improving fitness, preserving muscle, and boosting fat metabolism over time. Quotes to ponder: "Fat loss is a complicated process. There is no guarantee that working at a certain or target heart rate will lead to fat loss." "Mix up your workout routines. Incorporating variety into your workouts is probably the best thing to do." "Resistance training is the best way to make bigger muscles." Episode references: American College of Sports Medicine: https://www.acsm.org Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. John Liu joins Newly Erupted to share what he's learned from making the transition from private practitioner to academician, including how his residents help him learn daily. Dr. Liu and good friend and host Dr. Joel Berg discuss what factors impacted Dr. Liu's shift to teaching, including desire for a new work/life structure and a readiness to give back to the profession, and how impressed he is with the future of pediatric dentistry. Guest Bio: Born in Taipei, Taiwan, Dr. John Liu spent his childhood in Southern California. He graduated from Loma Linda University in La Sierra, California, with a BS degree in Biology. Dr. Liu went on to also receive his DDS degree from Loma Linda University's School of Dentistry and was accepted into the pediatric dental residency program at Children's Hospital in Cincinnati, Ohio. After 30 years of private practice in Issaquah, WA, Dr. Liu recently returned to Cincinnati Children's Hospital Medical Center as an assistant professor with a faculty appointment through the University of Cincinnati College of Medicine within the Division of Pediatric Dentistry and Orthodontics at CCHMC. While training future pediatric dentists, a primary focus of his work will be providing support to residents transitioning into the world of private practice and all it entails. Within AAPD, Dr. Liu has held a range of positions over the past decade, including as Board of Trustees Secretary/Treasurer, President-Elect, and 2010-2011 President. He is a Fellow of the American College of Dentists, served as president of the Washington State Academy of Pediatric Dentistry, chaired the Washington State Oral Health Coalition, and served on the boards of the Seattle Children's Museum and the Washington Dental Service Foundation. Nominated by his peers, Dr. Liu was inducted into the American College of Dentists in 1999, the Pierre Fauchard Academy in 2007, and the International College of Dentists in 2009. In 2013, Dr. Liu was honored as the AAPD Pediatric Dentist of the Year.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode Fred Goldstein invites Sheena Crosby, PharmD, BCGP, Inflammatory Bowel Disease Clinical Pharmacist at the Mayo Clinic in Florida. Sheena breaks down the American College of Gastroenterology's (ACG) updated guidelines for ulcerative colitis and Crohn's disease, highlighting major shifts in treatment strategy, including the move toward earlier use of advanced therapies and updated goals focused on symptom control, mucosal healing, and sustained remission. She also outlines the critical payer considerations emphasized in the guidelines—from eliminating unnecessary step-therapy requirements to ensuring timely access to induction and maintenance therapy—changes that have direct implications for patient outcomes and health-system performance. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

(0:00) Intro(1:31) About the podcast sponsor: The American College of Governance Counsel.(2:18) Start of interview. *Reference to prior episodes with David (E24 from Nov 2020 and E159 from Dec 2024)(3:22) 2025 highlights from the American College of Governance Counsel(4:55) The Rome Conference on AI, Ethics, and the Future of Corporate Governance(6:52) The Dual-Class Share Debate (reference to his paper Performance Leads Governance)(12:06) Emerging Governance Structures in AI companies, including Public Benefit Corporations (PBCs) "mission driven"(23:02) The AI Bubble Debate ("from a technology standpoint, I don't think we're in a bubble. From a valuation standpoint, we may be very well in a bubble.") Reference to my article on AI Washing Goes Criminal.(27:00) Big Tech vs. Little Tech Dynamics "We're going to have, at some point, a shakeout. It's impossible for all of these companies to be successful."(29:55) The Shift to Private Markets(34:15) Delaware's Governance Challenges (*reference to E194 on Silicon Valley 150 Report) "Since TripAdvisor, about 50 companies have left Delaware."(39:45) AI and Cybersecurity in the Boardroom(40:42) On Mandatory Arbitration(42:03) Biggest winner in business in 2025: Tech broadly, Silicon Valley particular.(43:40) Biggest loser in business in 2025: Delaware(45:15) Biggest business surprise in 2025(47:19) Best corporate governance trend from 2025: Renewed and strong focus on ethics.(50:00) Worst corporate governance trend from 2025: Partisanship(50:58) What's the biggest corporate governance trend to watch out for in 2026: the role of politics in the boardroom(51:35) One piece of advice for directors heading into 2026: the role of AI in the boardroom and in the companyDavid Berger is a partner at Wilson Sonsini and the President of the American College of Governance Counsel. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

With the end of 2025 upon us, we wanted to find some of the short stack conversations from the past year. So for this short stack, you'll here our 4 hosts, and frequent guests Matt Delaney and Christ Colbert join us for some random questions that will leave you laughing. Don't forget, we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more about an upcoming CME event!

How Much Vitamin B12 Do We Need Each Day? How are the recommended daily and weekly doses of vitamin B12 derived? And how much fortified food or supplements do we need to take? Listen to today's episode written by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #Plantbasednutrition #b12   ===================== Original post: https://nutritionfacts.org/video/how-much-vitamin-b12-do-we-need-each-day/  ====================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity.   FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

PDFs available here: https://rhesusmedicine.com/pages/cardiologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Timestamps:0:00 What is Heart Failure / Heart Failure Definition0:11 Systolic vs Diastolic Heart Failure 0:31 How is Cardiac Output Calculated2:28 Causes of Heart Failure 4:39 Heart Failure Risk Factors5:24 Signs and Symptoms of Heart Failure6:12 Diagnosis of Heart Failure 7:41 Treatment of Heart Failure (HFrEF vs HFpEF) ReferencesNaing, P., Forrester, D., Kangaharan, N., Muthumala, A.S.M., Myint, S.M. & Playford, D., 2019. Heart failure with preserved ejection fraction. July 2019. [online] Available at: https://www1.racgp.org.au/ajgp/2019/july/heart-failure-with-preserved-ejection-fraction. RACGPLi, P., Zhao, H., Zhang, J., Ning, Y. & Tu, Y., 2021. Similarities and differences between HFmrEF and HFpEF. , 8:678614. [online] Available at: https://www.frontiersin.org/articles/10.3389/fcvm.2021.678614/full. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding, National Center for Biotechnology Information (NCBI), 2020.  Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016826/. NCBIAlbakri, A., 2018. Heart failure with reduced ejection fraction: clinical status and meta-analyses of diagnosis by 3D echocardiography and natriuretic peptides-guided therapy. Paolucci, L., 2022. New guideline-directed treatments for heart failure. Journal of the American College of Cardiology: Case Reports. Available at: https://www.jacc.org/doi/10.1016/j.jaccases.2021.11.006. jacc.orgNicolas, D., 2024. Sacubitril-Valsartan. In: StatPearls . Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK507904/. NCBINational Center for Biotechnology Information (NCBI), 2024. Heart failure: diagnosis, management and prognosis. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961993/.National Center for Biotechnology Information (NCBI), 2024. Heart failure with preserved ejection fraction (HFpEF). Available at: https://www.ncbi.nlm.nih.gov/books/NBK599960/. NCBIDisclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

igraine disorders affect more than 1 billion people across the globe, yet they remain deeply misunderstood. In this episode, I sit down with Dr. Adam Harcourt to explore the true nature of migraines as a genetic neurological condition and to uncover why so many patients struggle to find lasting relief. Together, we examine the roots of migraine expression, including genetic vulnerability, environmental triggers, hormonal shifts, and the lifestyle factors that amplify neurological stress. Our conversation also dives into the complex relationship between concussion and migraine. These conditions often overlap, or they are mistaken for one another, which can delay the right treatment. Dr. Harcourt explains how functional neurological assessments can help clinicians identify the specific pathways involved and create targeted strategies that match the needs of each patient. We then discuss one of the most promising tools in migraine care: low-level laser therapy. Dr. Harcourt outlines how laser applications can reduce inflammation, support neural recovery, and help patients build resilience against recurring episodes. This episode offers science, clarity, and practical hope for anyone who lives with migraines or treats them in clinical practice.   Key takeaways: Genetic Disposition and Migraine: Migraines are primarily genetically mediated neurological disorders, with significant variations in expression and symptoms, often unrelated to pain. The Bucket Theory: Dr. Harcourt explains how stressors fill up a "bucket," causing migraines when they overflow, highlighting the need for both reducing stressors and expanding the "bucket." Concerns of Misdiagnosis: Many individuals are misdiagnosed with migraine when they may be suffering from post-concussion syndrome, underscoring the importance of precise diagnosis. Therapeutic Innovations: The discussion highlights the potential of low-level laser therapy in treating migraines, offering a non-invasive alternative to Botox and medication. Holistic Approach to Treatment: Emphasizing diet, hormone balance, and neuro-rehabilitation, Dr. Harcourt advocates for an integrated approach to effectively manage and prevent migraines. More About Dr. Adam Harcourt:   Dr. Adam Harcourt is the owner of Harcourt Brain Center currently located in York, PA, with offices formerly in Santa Barbara and Beverly Hills  CA. He is a Fellow of the American College of Functional Neurology (FACFN), Fellow of the American Board of Vestibular Rehabilitation (FABVR), Diplomate of the American Chiropractic Neurology Board (DACNB), and a 4th generation Doctor of Chiropractic. Dr. Harcourt is also an Associate Professor of Clinical Neurology at Carrick Institute for Graduate Studies, where he developed a 150-hour post-doctoral program,  titled 'Mastering Migraine', with which he instructs doctors from all different backgrounds from around the world. Website Instagram Connect with me! Website Instagram Facebook YouTube

In the 200th episode of Health & Veritas, Harlan offers end-of-the-year reflections on medicine drawn from his editor's notes in JACC (the Journal of the American College of Cardiology), and Howie provides updates on gun violence, flu, measles, and the health benefits of yoga. Show notes: Editor's notes by Harlan Krumholz "The Day I Became a Doctor" "When Your Patient Dies" "Rethinking Physician Certification: A Call for a Modern, Meaningful Standard" Gun violence, flu, and measles "Mass shootings outnumber annual days in U.S., children are missing school due to measles, Covid-19 is peeping around the corner, and some hope" "Measles outbreaks worsen in South Carolina, Arizona and Utah" "Connecticut reports first measles case in years" "New Flu Variant May Be Triggering Spike in Severe Disease" "High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults" "Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance" The benefits of yoga "Yoga for chronic non‐specific low back pain" "Yoga-based interventions may reduce anxiety symptoms in anxiety disorders and depression symptoms in depressive disorders: a systematic review with meta-analysis and meta-regression" "Effect of Yoga on Frailty in Older Adults" "Yoga in autoimmune disorders: a systematic review of randomized controlled trials" "Long-term effects of yoga-based practices on neural, cognitive, psychological, and physiological outcomes in adults: a scoping review and evidence map" "Yoga isn't just for flexibility. It may also protect brain health." In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Chegou o episódio escolhido por vocês! Marcela Belleza e Joanne Alves convidam Carol Millon para conversar sobe 6 clinicagens de inibidores de SGLT2, as gliflozinas:Indicações além do DMRisco de CAD euglicêmicaQuando não usar?⁠Cuidados com doença aguda (sick day) e hipovolemia⁠Cuidados pré-operatórioRisco de fratura e amputaçãoReferências:1. Bailey CJ, et al. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. Published 2013 Feb 20. doi:10.1186/1741-7015-11-432. Bersoff-Matcha SJ, et al. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019;170(11):764-769. doi:10.7326/M19-00853. Chang HY, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-1198. doi:10.1001/jamainternmed.2018.3034 4. Clar C, et al. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012 Oct 18;2(5):e001007. doi: 10.1136/bmjopen-2012-001007. PMID: 23087012; PMCID: PMC3488745.5. Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583. 6. Fralick M, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. Published 2020 Aug 25. doi:10.1136/bmj.m28127. Li D, et al. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355. doi:10.1111/dom.128258. Neal B, et al. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J. 2013;166(2):217-223.e11. doi:10.1016/j.ahj.2013.05.0079. Nyirjesy P, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173-1178. doi:10.1185/03007995.2012.69705310. Perkovic V, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-2306. doi:10.1056/NEJMoa181174411. Rosenwasser RF, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.12. Sridharan K, Sivaramakrishnan G. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opin Drug Saf. 2025;24(7):797-804. doi:10.1080/14740338.2024.237775513. Ueda P,  et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018;363:k4365. Published 2018 Nov 14. doi:10.1136/bmj.k436514. Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Jan;101(1):157-66. doi: 10.1210/jc.2015-3167. Epub 2015 Nov 18. PMID: 26580237; PMCID: PMC4701850.15. Zhuo M, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021;4(10):e2130762. Published 2021 Oct 1. doi:10.1001/jamanetworkopen.2021.3076216. Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho,  Antonio Carlos Aguiar Brandão, Ruy Lyra e Marcello Bertoluci. Rastreamento e Controle da Hiperglicemia no Perioperatório – Posicionamento Conjunto da Sociedade Brasileira de Diabetes (SBD), Sociedade Brasileira de Anestesiologia (SBA) e Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO). Diretriz Oficial da Sociedade Brasileira de Diabetes (2025). DOI: 10.29327/5660187.2025-10 , ISBN: 978-65-5941-367-6.17. Singh LG, Ntelis S, Siddiqui T, Seliger SL, Sorkin JD, Spanakis EK. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2024;47(6):933-940. doi:10.2337/dc23-112918. Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Endocr Pract. 2022;28(9):884-888. doi:10.1016/j.eprac.2022.06.00619. Umapathysivam MM, Morgan B, Inglis JM, et al. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw Open. 2024;7(3):e242744. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.274420. Fleming N, Hamblin PS, Story D, Ekinci EI. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. J Clin Endocrinol Metab. 2020;105(8):dgaa200. doi:10.1210/clinem/dgaa20021. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi:10.1016/S2213-8587(19)30256-622. Braunwald E. Gliflozins in the Management of Cardiovascular Disease. N Engl J Med. 2022;386(21):2024-2034. doi:10.1056/NEJMra211501123. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa150472024. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377(7):644-657. doi:10.1056/NEJMoa161192525. Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa181238926. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa191130327. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJMoa202219028. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa210703829. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa202481630. The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in...

 Fertility Docs Uncensored is hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center. In this episode, the docs welcome visiting physician Dr. Shelley Dolitsky from Shady Grove Fertility in Towson, Maryland, for an in-depth conversation about recurrent pregnancy loss. Dr. Dolitsky begins by reviewing how different professional organizations define recurrent pregnancy loss. The American Society for Reproductive Medicine considers two or more losses—including very early biochemical losses—to be recurrent pregnancy loss, while the American College of OB/GYN defines it as two clinical losses under 20 weeks. The docs discuss how age dramatically affects miscarriage risk, with up to 75% of women over 40 experiencing miscarriages, compared with an overall rate of three to five percent. They walk through the full evaluation, which includes assessing the uterine cavity for abnormalities such as scar tissue, polyps, or congenital malformations; ensuring the fallopian tubes are normal and ruling out tubal damage; and performing chromosome analysis on both partners. Testing for antiphospholipid antibodies and lupus anticoagulant is also essential, as these can contribute to placental clotting issues. The conversation highlights the importance of screening for chronic medical issues that might be undiagnosed. About half of patients with recurrent pregnancy loss will have an identifiable and often treatable cause. Finally, the team discusses recommendations for patients whose workup is normal but who continue to experience losses. This podcast was sponsored by Shady Grove Fertility. 

It's YOUR time to #EdUp with Dr. Eric Klein, Assistant Provost, Doctoral Research & Student Success, American College of EducationIn this episode, part of our Academic Integrity Series, sponsored by ⁠Integrity4EducationYOUR cohost is Thomas Fetsch, CEO, Integrity4EducationYOUR host is ⁠Elvin Freytes⁠How does an online university grow enrollment by doubling every year for 5 years while maintaining 85% graduation rates & 95% student satisfaction without raising tuition since 2016?What happens when an institution refuses Title IV funding & offers master's degrees for under $10,000 & doctoral programs under $25,000 while delivering $19.20 in ROI for every $1 students invest?How does a focus on transparency & student centeredness through personalized pathways, immersive VR learning & clear job placement data prepare 12,000 students for lifelong learning in an AI enabled world?Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠& ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr. Joe Sallustio⁠⁠⁠⁠⁠● Join YOUR EdUp community at ⁠The EdUp Experience⁠We make education YOUR business!P.S. Want to get early, ad-free access & exclusive leadership content to help support the show? Then ⁠⁠​subscribe today​⁠⁠ to lock in YOUR $5.99/m lifetime supporters rate! This offer ends December 31, 2025!

What if the key to self-advocacy wasn't being louder—but rewiring how you think, feel, and connect with empathy?Today, I'm joined by executive coach and podcast host Jamie Lee, who specializes in helping women and underrepresented leaders rise through the ranks without compromising their integrity. We dive into how empathy and neuroplasticity form the foundation of effective self-advocacy — and how rewiring internal narratives can lead to greater confidence, deeper connection, and clarity when speaking up. Jamie shares evidence-based techniques for regulating the nervous system so you can show up with presence and poise in high-stakes conversations. Plus, we touch on the six types of intelligence you can access to build connections and ask for what you want.If you've ever struggled with self-advocacy or want to communicate with more impact and empathy, this episode is for you.To access the episode transcript, go to www.TheEmpathyEdge.com, search by episode title.Listen in for…Defining self-advocacy and neuroplasticity in terms of empathy. Compassion as an action is the key to rewiring your brain. Ways to access your parasympathetic nervous system in your thinking brain and get out of your automatic stress response.Leveraging mirror neurons with empathy and compassion. "The brain adapts. The brain grows. It changes according to the practices that you expose it to. Compassion is the missing link that helps us be able to access those self-advocacy muscles for ourselves." — Jamie Lee Episode References: Book a free hour-long consultation for 1:1 coaching with Jamie: https://www.jamieleecoach.com/applyThe Empathy Edge podcast: Dia Bondi: How to Ask Like an AuctioneerMelissa Tiers' Anti-Anxiety Toolkit: https://www.amazon.com/Anti-Anxiety-Toolkit-Melissa-Tiers-ebook/dp/B0073HU3EGJames Tripp's website: https://www.jamestripp.onlineAbout Jamie Lee, Coach, Trainer, Podcast Host Jamie is an executive coach who specializes in women and underrepresented leaders who are "allergic" to office politics. She focuses on helping them get promoted and better paid without compromising their integrity or throwing anyone under the bus. In her practice, she blends proven self-advocacy strategies with evidence-based neuroplasticity tools.Over a decade, Jamie has trained thousands of professionals in effective self-advocacy at leading organizations, including Citi, Unilever, Association of Corporate Counselors, American College of Cardiologists, UC Berkeley School of Business, and Smith College.She's also the host of the Risky Conversations podcast, where she has honest talks with thought leaders on topics often considered taboo or "too risky" at work -- negotiation, mental and reproductive health, office politics, social injustices, and unconventional ways smart women navigate their path forward despite a flawed workplace. From Our Sponsor:Keynote Speakers and Conference Trainers: Get your free Talkadot trial and enjoy this game-changer for your speaking business! www.share.talkadot.com/mariaross Connect with Jamie:Jamie Lee Coach: jamieleecoach.com LinkedIn: linkedin.com/in/leejieunjamie Instagram: instagram.com/jamieleecoach Connect with Maria:Get Maria's books: Red-Slice.com/booksHire Maria to speak: Red-Slice.com/Speaker-Maria-RossTake the LinkedIn Learning Courses! Leading with Empathy and Balancing Empathy, Accountability, and Results as a Leader LinkedIn: Maria RossInstagram: @redslicemariaFacebook: Red SliceKeynote Speakers and Conference Trainers: Get your free Talkadot trial and enjoy this game changer for your speaking business! www.share.talkadot.com/mariarossGet your copy of The Empathy Dilemma here- www.theempathydilemma.com

The OECD Report for Regional Policy for Greece Post-2020 (https://www.oecd.org/en/publications/regional-policy-for-greece-post-2020_cedf09a5-en.html) revealed that 32% of the population lives in predominantly rural regions which is significantly higher than the OECD average share of rural population which is around 25%. Of those living in predominantly rural regions (~3.4 million people), roughly 3 million live in remote rural regions meaning Greece has one of the largest shares in this demographic among OECD countries. Recorded live from the OECD Rural Development Conference in Rio de Janeiro, Greek officials Vasiliki Pantelopoulou (Secretary-General of the Partnership Agreement) and Christos Kyrkoglou (General Director of Monitoring and Implementation) explain Greece's approach to rural urban development under the European Union's Cohesion Policy and the role of Integrated Territorial Investments (ITIs). They describe their respective roles in coordinating and implementing programmes financed through the Partnership Agreement, stressing the importance of integrating urban and rural policies. Sit back, relax and take a listen! Vasiliki Pantelopoulou is a lawyer and a Member of Athens Bar Association. She graduated from School of Law of the National and Kapodistrian University of Athens and holds two postgraduate degrees (LL.M. in Commercial and Business Law from East Anglia University, U.K., and MSc in Business Administration for Law Practitioners from Alba Graduate Business School, The American College of Greece, Greece). She is a Member of the Board of the Hellenic Development Bank. She has worked for twenty years as an in-house lawyer at STASY – Urban Rail Transport S.A., specialized in the field of public procurement (Law 4412/2016). Since April 2023, she has been the Director of Legal Services at Metavasi S.A. – Hellenic Company for Just Transition S.A. She is a Member of investing Committees such as EQUIFUND I & II, TEPIX III Loan Fund and others. Christos Kyrkoglou is the General Director of Monitoring and Implementation for the ESPA, which operate under the Secretary General. Mr Kyrkoglou holds a Bachelor's Degree in Sociology from Panteion University of Social and Political Sciences, as well as a Master's Degree in Urban and Regional Development from the same institution. In 2023, he was appointed Head of the Special Service for the Coordination of Regional Programs of the General Secretariat for the Partnership Agreement of the Ministry of Economy and Finance. Since 2025, he is Head of the General Directorate for Monitoring and Implementation. His professional interests and fields of expertise span the full spectrum of development interventions under the Partnership Agreement for Regional Development 2021–2027, with a particular focus on employment, human resources development, innovation and entrepreneurship, social policy, territorial development, culture, and the environment. As Public Affairs and Communications Manager, Shayne engages with policy issues concerning SMEs, tourism, culture, regions and cities to name a few. He has worked on a number of OECD campaigns including “Going Digital”, "Climate Action" and "I am the future of work". **** To learn more, visit OECD Latin American Rural Development Conference www.oecd.org/en/events/2025/11/…nt-conference.html and the OECD's work on Rural Development www.oecd.org/en/topics/policy-i…l-development.html. Find out more on these topics by reading Reinforcing Rural Resilience www.oecd.org/en/publications/re…e_7cd485e3-en.html and Rural Innovation Pathways www.oecd.org/en/publications/ru…s_c86de0f4-en.html. To learn more about the OECD, our global reach, and how to join us, go to www.oecd.org/about/ To keep up with latest at the OECD, visit www.oecd.org/ Get the latest OECD content delivered directly to your inbox! Subscribe to our newsletters: www.oecd.org/newsletters

Fecal incontinence (FI) affects nearly 8% of adults worldwide, yet many people suffer in silence due to embarrassment, confusion, or the belief that nothing can be done. This episode is here to change that. We're joined by Dr. John William Blackett, gastroenterologist and lead author of "Fecal Incontinence in Adults: New Therapies," published in The American Journal of Gastroenterology. Dr. Blackett offers a compassionate, patient-centered overview of FI, including common causes, diagnostic testing, and the full range of treatment options available today—highlighting newer and emerging therapies. If you've experienced unexpected leakage, urgency, staining, or difficulty controlling bowel movements—or if you support someone who has—this conversation provides clarity, reassurance, and practical guidance. Effective treatments exist, and help is available. This episode is produced in collaboration with the American College of Gastroenterology Patient Care Committee.

Portability can be a powerful tool—until it isn't. In this new ACTEC Trust and Estate Talk episode, we break down Estate of Rowland v. Commissioner and how an incomplete estate tax return cost the surviving spouse $3.7 million in DSUE. Learn what went wrong, why the relaxed reporting rules didn't apply, and the key steps practitioners should take to safeguard a valid portability election. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

Soul Food That's Good for the Soul The best of soul food's origins are tied to the plant-centric West African diet. And that's soul food that's good for the soul! Listen to today's 7-min episode by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #Plantbasednutrition #veganpodcast #plantbasedpodcast #plantbasedbriefing #nutritionfacts #wfpb #soulfood #blackvegan #vegansoulfood ===================== Original post: https://nutritionfacts.org/video/soul-food-thats-good-for-the-soul/  ====================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity.   FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

In this episode of the Changing Higher Ed® podcast, Dr. Drumm McNaughton speaks with Dr. Ashley Finley, Vice President of Research and Senior Advisor to the President at the Association of American Colleges and Universities (AAC&U), about the findings of the 2025 AAC&U Employer Survey and what they reveal about employer expectations for higher education. Based on nearly 20 years of longitudinal research, the 2025 survey challenges many of the dominant public narratives about the value of college. Employers continue to express strong confidence in higher education, place equal importance on workforce preparation and citizenship, and increasingly emphasize adaptability, judgment, and civic capacity as core professional requirements. Dr. Finley explains how employers view civic skills as workplace competencies, why mindsets and dispositions are now baseline expectations rather than "soft skills," and how AI is reshaping what it means to be prepared for an uncertain future. The conversation also addresses generational differences among employers, the growing role of microcredentials, and why institutions must model the agility they expect from graduates. This episode is especially relevant for presidents, trustees, provosts, and senior leaders navigating political pressure, workforce alignment, and questions about institutional value. Topics Covered: What the 2025 AAC&U Employer Survey reveals that public narratives often miss Why employers see preparing informed citizens and a skilled workforce as inseparable goals How civic skills, including constructive disagreement, translate directly to workplace success Why motivation, resilience, initiative, and self-awareness are now baseline hiring expectations How employers think about AI readiness beyond simple tool proficiency Which student experiences increase hiring likelihood beyond internships How employers evaluate the credibility and value of microcredentials and certificates Generational shifts in employer expectations and what they signal for the future Three Takeaways for University Presidents and Boards: Institutions must communicate learning outcomes more clearly, including mindsets and dispositions, so students can articulate who they are becoming, not just what they know. Career-relevant experiences extend far beyond internships; leadership roles, campus employment, and community engagement carry significant employer value and are often more scalable. Agility must be modeled institutionally. Employers value adaptability, and colleges and universities cannot promote it in students while resisting change themselves. Bonus Takeaway from Dr. McNaughton: Employers continue to value higher education and the four-year degree, despite political rhetoric and cost-driven narratives suggesting otherwise. This disconnect presents both a risk and an opportunity for institutional leaders. This conversation offers data-grounded insight into how employers actually view higher education—and what leaders can do to align strategy, communication, and culture with those expectations. Read the full transcript: https://changinghighered.com/strategic-insights-2025-aacu-employer-survey/ #HigherEducation #HigherEducationLeadership #AACU #EmployerSurvey #WorkforceReadiness #ChangingHigherEdPodcast

Over 5 million people worldwide have been trained in the American College of Surgeons Stop the Bleed program. The program aims to make these life-saving skills as common as CPR. Following the Brown University shooting claiming the lives of two students and leaving nine others injured, we talk about the importance of trauma response skills from hospitals to the everyday bystander. We spoke with Dr. Shea Gregg, Chair of Surgery at SVMC and Chair of CT State Trauma Committee.

(0:00) Intro.(1:27) About the podcast sponsor: The American College of Governance Counsel.(2:14) Start of interview. *Reference to prior episodes/reports with Richard (E126 from Feb 2024 and E158 from Dec 2024)(3:11) AI dominance in public and private markets(4:14) About WSGR's 2025 SV150 Corporate Governance Report. Major Findings in DEI Disclosure (impact on board diversity)(12:25) Broader ESG Changes and Challenges to SEC Climate Disclosure Rule(16:03) California approach to climate risk disclosures (SB 253 and SB 261) and greenhouse gas emissions disclosure(19:04) State vs. Federal Regulatory Landscape(21:13) On SEC's change of policy relating to mandatory arbitration bylaws(23:41) SEC Changes Under Chair Atkins: changes in exec comp disclosures and removing quarterly reporting (27:18) SEC Changes to Rule 14a-8 proposals(29:23) On Lack of Minority Party SEC Commissioners(32:30) Delaware vs. Other States on Corporate Incorporations(39:26) Other findings from the 2025 report. Including on dual-class shares and sunset provisions.(41:12) The State of Private Markets, IPOs and VC(49:55) Biggest winner in business in 2025(50:55) Biggest loser in business in 2025(53:00)  Biggest business surprise in 2025(54:32) Best and worst corporate governance trend from 2025(58:18)  What's the biggest corporate governance trend to watch out for in 2026Richard Blake is a partner at Wilson Sonsini and the leader of the firm's public companies' practice. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Lee el blogpost completo: https://ecctrainings.com/cuidado-de-quemaduras-en-zonas-remotas-versus-combate-lecciones-cruzadas-entre-las-guias-jts-y-wms Únete al ECCnetwork en Circle: Sé parte de la comunidad que transforma la educación en emergencias. Activa tu membresía gratuita y accede a contenido exclusivo, foros y eventos. 

Vaccines are one of public health's greatest success stories—but what happens when people start saying no? In this episode, Kevin and Dr. Lisa Wolf dig into the rising tide of vaccine refusal, what's fueling it, and how it's already impacting what we see in the emergency department.  If you've ever struggled to explain vaccine science to a skeptical patient, this episode is essential listening. Resources mentioned: ·       American Academy of Pediatrics vaccination recommendations ·       American College of Obstetricians and Gynecologists vaccine guidelines ·       Studies on shingles vaccine and dementia reduction ·       HPV vaccine and cervical cancer elimination in Scotland ·       Vaccination in the emergency department study Follow us on: Facebook: https://www.facebook.com/Art-of-Emergency-Nursing-276898616569046/  YouTube: https://www.youtube.com/channel/UCJTnz4phtCTjojTIDJo2afA?view_as=subscriber  Twitter: @AoenPodcast Instagram: https://www.instagram.com/artofemergencynursing/  To support the show: Leave an honest review on iTunes. Your ratings and reviews greatly contribute to the success of the podcast, and I appreciate each and every one of them. Subscribe on Apple Podcasts, Google Podcasts, or your preferred podcast platform to never miss an episode. Thank you for being a part of our AOEN community!

Doctor Mau Informa ®️#drmauinforma 

Host Dr. Joe Patterson sits down with Drs. Michael Sutherland, Bryant Oliphant, and Jennifer Hagen to talk about the American College of Surgeons Committee on Trauma and how orthopedic trauma surgeons can get involved and benefit from the organization in daily practice. Live from the OTA 2025 Annual Meeting. For more information and to become an ACS member, click here. For additional educational resources visit OTA.org  

Welcome to the Legal Nurse Podcast, where complex medical topics meet the world of litigation. In this episode, host Pat Iyer sits down with Dr. Allison Muller, a seasoned toxicologist who brings her expertise to the forefront of the ongoing opioid crisis. Together, they delve into the multifaceted role opioids play in patient care, legal cases, and toxicology, offering invaluable insights for legal nurse consultants and medical professionals alike. Throughout their conversation, Pat Iyer and Allison Muller unpack the intricacies of opioid administration, the significance of accurate medical record documentation, and the challenges of interpreting toxicology reports, especially in postmortem cases. Dr. Muller sheds light on key concepts such as opioid tolerance versus naivety, risks of over-sedation, and the life-saving but often misunderstood role of naloxone in reversing opioid overdoses. Whether you're navigating your first toxicology-related case or looking to deepen your understanding of opioid implications in acute care settings, this episode offers practical guidance and real-world examples. From common pitfalls in toxicology interpretation to the criteria for bringing a toxicologist onto your legal team, Dr. Muller and Pat Iyer provide a roadmap for safer patient care and stronger case outcomes. What you'll learn in this episode on Navigating Opioid Cases: Insights from a Toxicologist on Medical Records and Overdose Risks Here are five intriguing questions that this podcast answers: How should medical records be reviewed to accurately track opioid administration in acute care settings, and what are the limitations of toxicology blood levels in this context? Why do toxicology reports from autopsies take so long to be completed, and what complexities are involved in determining the substances present in a decedent's system? What is the difference between opioid naive and opioid tolerant patients, and why is understanding these distinctions critical for safe opioid prescribing? What are the best practices for administering Naloxone (Narcan) in cases of opioid overdose, and why is timing so crucial for its effectiveness? When is it appropriate for a legal nurse consultant to recommend involving a toxicologist in a case, especially when interpreting complex toxicology results? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. Grow Your LNC Business 13th LNC SUCCESS® ONLINE CONFERENCE April 23, 24, and 25, 2026 Skills, Strategy, Results Gain deposition mastery, marketing confidence, and clinical–legal insight from industry leaders you can apply to your next case and client call. Build a Practice Attorneys Remember Learn exactly how to showcase expertise, attract referrals, and turn complex medical records into clear, defensible stories that win trust. Learn From the Best—Then Ask Them Anything Get step-by-step training, live “hot seat” solutions, and exclusive VIP Q&A time with Pat Iyer to accelerate your LNC growth. Register now- Limited spots available Your Presenters for Navigating Opioid Cases: Insights from a Toxicologist on Medical Records and Overdose Risks Pat Iyer Pat Iyer is a seasoned legal nurse consultant and business coach renowned for her expertise in guiding new legal nurse consultants to successfully break into the field. As the host of the Legal Nurse Podcast, Pat addresses critical challenges that legal nurse consultants face, such as difficulty in landing clients and lack of response from attorneys. Through her insightful episodes, she emphasizes the importance of effectively communicating one's value to potential clients. With a wealth of experience, Pat has empowered countless consultants to overcome these hurdles and thrive in their careers. Connect with Pat Iyer by email at patiyer@legalnusebusiness.com Allison Muller Toxicologist with a passion for science, family, and the outdoors. Board-certified clinical toxicologist, fellow of the American Academy of Clinical Toxicology, affiliate fellow of the American College of Medical Toxicology, and faculty at the University of Pennsylvania School of Veterinary Medicine. Scientist with a flair for explaining the hard stuff to the triers of fact and anyone who wants to learn toxicology! When she isn't on this podcast, she's caring for an orange tabby cat and a dwarf bunny (luckily the tabby doesn't know his best friend is a bunny!) Connect with Allison Muller by email at Allison@AcriMullerConsulting.com

Monday, December 8th, 2025Today, Brian Cole confessed to planting the pipe bombs the night before the insurrection and is a MAGA election denier; the developer of the ICE Block app is suing officials from DHS ICE DOJ and the White House; the DOJ is considering taking a third swipe at getting a grand jury to indict NYAG Letitia James; the Government Accountability Office is investigating Bill Pulte - the guy who made all the mortgage fraud referrals to DOJ; the Indiana House advances it's 9-0 map to the Senate; the DOJ has already started stonewalling judge Boasberg in his contempt proceedings against against government officials; Rep Adelita Grijalva was pepper sprayed by ICE after identifying herself as a Congresswoman; Kash Patel ordered a tactical SWAT guy to give his girlfriend's drunk pal a ride home; an internal BOP memo halts rape protections for trans inmates; the Department of Health and Human Services deadnamed an official on her portrait; a judge has ordered the unsealing of Epstein grand jury materials; and Allison and Dana deliver and your Good News.Guest: Joshua Aaron of ICEBlock apphttps://www.iceblock.apphttps://bsky.app/profile/joshua.stealingheather.comhttps://www.tixeconsulting.comGuest: Deirdre von DornumProminent federal criminal defense attorney - 23 years at Federal Defenders of New York - Attorney-in-Charge for the Eastern District; Fellow of the American College of Trial Lawyers. Specializing in complex federal cases, indigent defense, civil rights, and pro bono work.https://www.youtube.com/@MSWMediaPodsStoriesDrag queen Pattie Gonia completes 100-mile trek raising $1m to make outdoors more ‘equitable' | California | The GuardianRep. Adelita Grijalva says she was 'sprayed in the face' during ICE confrontation | NBC NewsIndiana House GOP advances 9-0 congressional map, sending contentious plan to state Senate | CBS NewsPipe bomb suspect confesses and has expressed support for Trump, sources say | MS NOWKash Patel ordered FBI detail to give girlfriend's pal a lift home: sources | MS NOWDOJ won't say what it advised Noem amid contempt inquiry over El Salvador deportations | ABC NewsHHS changed the name of transgender health leader on her official portrait | NPR NewsGovernment Accountability Office opens investigation into FHFA chief Bill Pulte | NBC NewsDOJ orders prison inspectors to stop considering LGBTQ safety standards | NPRJudge orders unsealing of grand jury transcripts from Epstein case in Florida | CBS NewsGood Troublehttps://near.tl/sm/ik-ZushRaEllen She/HerRhode Island continues to fight ICE. Ice vehicles are routinely spotted parked near or circling the courthouse. A WhatsApp text goes out to be present and witness/ hopefully prevent ice kidnappings. If you are a RI local, please sign up. If not, your community likely has something similar.Ice Watch RI WhatsApp channel:‎Follow the Alerta de Migra / ICE Watch RI channel on WhatsApp: https://whatsapp.com/channel/0029VbBK6Y229759BqNu3p2mPROTECT YOURSELF AND YOUR COMMUNICATIONS WHEN USING WHATSAPP:https://securityinabox.org/en/tools/whatsappFront Line Defenders:https://www.frontlinedefenders.org/enJoin Dana and The Daily Beans and support on Giving Tuesdayhttp://onecau.se/_ekes71From The Good Newshttps://www.aafront.org/fbklivehttps://www.mprnews.org/story/2025/12/02/escalation-of-rhetoric-from-white-house-targeting-somalis-is-unhinged-says-somali-scholarhttps://www.summitdogrescue.org/meet-fressi--fresita.html→Please submit your own at https://DailyBeansPod.com - click on ‘Good News and Good Trouble'Our Donation Linkshttps://www.nationalsecuritylaw.org/donate, https://secure.actblue.com/donate/msw-bwc, http://WhistleblowerAid.org/beansFederal workers - email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen.Dr. Allison Gill - https://muellershewrote.substack.com, https://bsky.app/profile/muellershewrote.com, https://instagram.com/muellershewrote, https://twitter.com/MuellerSheWrote, https://www.youtube.com/@MSWMediaPodsDana Goldberg - https://bsky.app/profile/dgcomedy.bsky.social, https://twitter.com/DGComedy, https://www.instagram.com/dgcomedy, https://www.facebook.com/dgcomedy, https://danagoldberg.comMore from MSW Media - https://mswmedia.com/shows, Cleanup On Aisle 45 pod, https://muellershewrote.substack.comReminder - you can see the pod pics if you become a Patron. The good news pics are at the bottom of the show notes of each Patreon episode! That's just one of the perks of subscribing! patreon.com/muellershewrote Our Donation LinksNational Security Counselors - DonateMSW Media, Blue Wave California Victory Fund | ActBlueWhistleblowerAid.org/beansFederal workers - feel free to email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Find Upcoming Actions 50501 Movement, No Kings.org, Indivisible.orgDr. Allison Gill - Substack, BlueSky , TikTok, IG, TwitterDana Goldberg - BlueSky, Twitter, IG, facebook, danagoldberg.comCheck out more from MSW Media - Shows - MSW Media, Cleanup On Aisle 45 pod, The Breakdown | SubstackShare your Good News or Good TroubleMSW Good News and Good TroubleHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?The Daily Beans | SupercastThe Daily Beans & Mueller, She Wrote | PatreonThe Daily Beans | Apple Podcasts Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Contributor: Aaron Lessen, MD Educational Pearls: How do amiodarone and lidocaine work on the heart? Amiodarone Blocks potassium channels (Class III effect). Also blocks sodium and calcium channels. Additional noncompetitive beta-blocker effects. Stabilizes cardiac tissue, slows heart rate, and suppresses both atrial and ventricular arrhythmias. Lidocaine Blocks fast sodium channels in ventricular tissue (Class Ib). Shortens the action potential in ventricular myocardium, especially in ischemic tissue. Suppresses abnormal automaticity in damaged/irritable myocardium. Which one should you pick for a patient in vtach/vfib cardiac arrest? The current guidelines recommend amiodarone for shock-refractory cases but this is based on randomized trials showing better arrhythmia termination and short-term outcomes, but not long-term survival benefits. Two recent studies suggest that lidocaine might actually be preferable. A 2023 paper published in Chest Performed a large retrospective cohort study for treating in-hospital VT/VF cardiac arrest. Among more than 14,000 patients, lidocaine was associated with higher rates of ROSC, 24-hour survival, survival to discharge, and favorable neurologic outcomes. These results held after adjusting for covariates and using propensity score methods. Overall, lidocaine outperformed amiodarone across all major clinical outcomes in this population. A 2025 paper published in Resuscitation Performed a target trial emulation in adults with out-of-hospital shockable cardiac arrest. After propensity score matching in more than 23,000 eligible cases, lidocaine was associated with higher odds of prehospital ROSC, fewer post-drug defibrillations, and greater survival to hospital discharge. These advantages were consistent across matched patient pairs. Dose for lidocaine is an initial 1-1.5 mg/kg IV bolus, followed by additional boluses of 0.5-0.75 mg/kg every 5-10 minutes up to a total of 3 mg/kg if needed. Dose for amiodarone is a 300 mg bolus followed by an additional 150 mg bolus if needed. References Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035. Epub 2017 Oct 30. Erratum in: Heart Rhythm. 2018 Nov;15(11):e278-e281. doi: 10.1016/j.hrthm.2018.09.026. PMID: 29097320. Smida T, Crowe R, Price BS, Scheidler J, Martin PS, Shukis M, Bardes J. A retrospective 'target trial emulation' comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation. Resuscitation. 2025 Mar;208:110515. doi: 10.1016/j.resuscitation.2025.110515. Epub 2025 Jan 23. PMID: 39863130; PMCID: PMC11908894. Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RW. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Chest. 2023 May;163(5):1109-1119. doi: 10.1016/j.chest.2022.10.024. Epub 2022 Nov 2. PMID: 36332663. Summarized by Jeffrey Olson, MS4 | Edited by Jeffrey Olson and Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462 Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You'll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients' quality of life. Episode resource links: El Hussein, M. T., & Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501. Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... & Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578. Charles, A. C., Tepper, S. J., & Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain. Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025 Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... & Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

For this episode hosts Drew, Tanner, and Andy are joined by performance scientist Jason Brooks to discuss the topic of Mental Interference. Do't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org to learn more about this organization and how you can attend a future CME event!

(0:00) Intro(1:21) About the podcast sponsor: The American College of Governance Counsel(2:08) Start of interview(2:36) Michelle's origin story(4:33) The Origins of Footnoted (started in 2003)(6:36) Understanding SEC Filings and Disclosures(7:20) The "Friday Night Dump"(9:34) The State of Public vs. Private Markets(12:40) The Rise of Private Markets and Challenges of Public Markets(18:43) Red Flags in SEC Filings(22:03) The Evolution of Executive Compensation and Elon Musk's Comp(28:53) Egregious Corporate Governance examples: Sketchers.(30:08) The problem of Related Party Transactions.(31:37) Independence and Compensation of Board Members (32:36) Quote of Charlie Munger and Warren Buffett on this topic(36:33) Are we in a AI bubble? Similarities with Enron/Worldcom era? (40:18) Reference to my article on AI washing(41:43) The Importance of SEC Changes (only 3 commissioners from a single party)(43:22) The Role of Markets in Everyday Life(47:45) Books that have greatly influenced her life:The Jungle by Upton Sinclair (1906)Germinal by Émile Zola (1885)Crying in H Mart by Michelle Zauner (2021)(48:20) Her mentors: Nell Minow, Diana Henriques, and Thornton O'Glove.(49:19) Quotes that she thinks of often or lives her life by: "Don't Postpone Joy"(50:52) An unusual habit or an absurd thing that she loves. Michelle Leder is the founder and editor-in-chief of footnoted.com, a source for uncovering important information hidden deep in SEC filings.  You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Peter Robbins returns to the show, and we talk about his return to the UK and Rendlesham, and then get into the life and research of Wilhelm Reich. If you are not familiar with the man, you should be. You will see why on this show. Peter is of course best known for his work on the Rendlesham Forest case, but has an extensive resume dealing with Reich as well. Peter Robbins was first introduced to the books of Wilhelm Reich as a teenager by a college roommate, to whom he remains deeply indebted. In 1976 he met Dr. Elsworth F. Baker, Reich's first assistant for the last eleven years of his life. Soon after this he became a patient of Dr. Baker and entered into almost seven years of medical orgone therapy with the distinguished orgonomist.Robbins went on to enroll in the classes New York University offered in scientific and social orgonomy which was taught by the Reich scholars Professors John Bell and Paul Matthews. They in turn invited him to become a member of their ongoing Seminar in Social and Scientific Orgonomy, patterned after the seminars which Sigmund Freud presided over during the nineteen twenties. Peter spent much of the nineteen eighties involved with this group, presenting a variety of papers to his fellow seminar members under Matthews' and Bell's guidance and leadership.Peter was a volunteer fundraiser for the American College of Orgonomy's (ACO) Building Fund and had two papers on Wilhelm Reich and UFOs published in the Journal of Orgonomy. He was part of a select group of volunteers invited to witness a demonstration of cloudbusting technology and presented on the subject of Reich and UFOs at the ACO's Princeton NJ facility, and at international conferences on the life and work of Reich in New York City, Ashland Oregon, Niece France and Karavomilos Greece. His lectures have been well received at numerous scientific and UFO conferences both here and abroad while his articles on the subject have been published in a variety of print and web publications. Robbins' extensively researched paper, “Politics, Religion and Human Nature: Practical Problems and Roadblocks on the Path Toward Official UFO Acknowledgment” is scheduled to be published in the upcoming issue of Annals of the Institute for Orgonomic Science. Hosted on Acast. See acast.com/privacy for more information.

In this episode, the CardioNerds (Dr. Naima Maqsood, Dr. Akiva Rosenzveig, and Dr. Colin Blumenthal) are joined by renowned educator in electrophysiology, Dr. Joshua Cooper, to discuss everything atrial flutter; from anatomy and pathophysiology to diagnosis and management. Dr. Cooper's expert teaching comes through as Dr. Cooper vividly describes atrial anatomy to provide the foundational understanding to be able to understand why management of atrial flutter is unique from atrial fibrillation despite their every intertwined relationship. A foundational episode for learners to understand atrial flutter as well as numerous concepts in electrophysiology. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah.  CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls "The biggest mistake is failure to diagnose”. Atrial flutter, especially with 2:1 conduction, is commonly missed in both inpatient and outpatient settings so look carefully at that 12-lead EKG so you can mitigate the stroke and tachycardia induced cardiomyopathy risk  Decremental conduction of the AV node makes it more challenging to rate control atrial flutter than atrial fibrillation  Catheter Ablation is the first line treatment for atrial flutter and is highly successful, but cardioversion can be utilized as well prior to pursuing ablation in some cases.  Class I AADs like propafenone and flecainide may stability the atrial flutter circuit by slowing conduction and thus may worsen the arrhythmia. Therefore, the preferred anti-arrhythmic medication in atrial flutter are class III agents.  Atrial flutter can be triggered by firing from the left side of the heart, so in patients with both atrial fibrillation and flutter, ablating atrial fibrillation makes atrial flutter less likely to recur.  BONUS PEARL: Dr. Cooper's youtube video on atrial flutter is a MUST SEE!  Notes Notes: Notes drafted by Dr. Akiva Rosenzveig  What are the distinguishing features of atrial fibrillation and flutter?  Atrial flutter is an organized rhythm characterized by a wavefront that continuously travels around the same circuit leading to reproducible P-waves on surface EKG as well as a very mathematical and predictable relationship between atrial and ventricular activity  Atrial fibrillation is an ever changing, chaotic rhythm that consists of small local circuits that interplay off each other. Consequently, no two beats are the same and the relationship between the atrial activity and ventricular activity is unpredictable leading to an irregularly irregular rhythm  What are common atrial flutter circuits?  Cavo-tricuspid isthmus (CTI)-dependent atrial flutter is the most common type of flutter. It is characterized by a circuit that circumnavigates the tricuspid valve.  Typical atrial flutter is characterized by the circuit running in a counterclockwise pattern up the septum, from medial to lateral across the right atrial roof, down the lateral wall, and back towards the septum across the floor of the right atrium between the IVC and the inferior margin of the tricuspid valve i.e. the cavo-tricuspid isthmus. Surface EKG will show a gradual downslope in leads II, III, and AvF and a rapid rise at end of each flutter wave.   Atypical CTI-dependent flutter follows the same route but in the opposite direction (clockwise). Therefore, we will see positive flutter waves in the inferior leads   Mitral annular flutter is more commonly seen in atrial fibrillation patients who've been treated with ablation leading to scarring in the left atrium.  Roof-dependent flutter is characterized by a circuit that travels around left atrium circumnavigating a lesion (often from prior ablation), traveling through the left atrial roof, down the posterior wall, and around the pulmonary veins  Surgical/scar/incisional flutter is seen in people with a history of prior cardiac surgery and have iatrogenic scars in right atrium due to cannulation sites or incisions  How does atrial flutter pharmacologic management differ from other atrial arrhythmias?  The atrioventricular (AV) node is unique in that the faster it is stimulated, the longer the refractory period and the slower it conducts. This characteristic is called decremental conduction. In atrial fibrillation, the atrial rate is so fast that the AV node becomes overwhelmed and only lets some of those signals through to the ventricles creating an irregular tachycardia but at lower rates. In atrial flutter, the atrial rate is slower, therefore the AV node has more capability to conduct allowing for higher ventricular rates. Therefore, to achieve rate control one will need a higher dose of AV blocking medications. Atrial tachycardia may require even higher doses due to the increased ability of the AV node to conduct, as the atrial rates are slower than in atrial flutter.  Sodium channel blockers (Class I) such as flecainide and propafenone slow wavefront propagation, making it easier for the AV node to handle the atrial rates. This will end up leading to increased ventricular rates which can be dangerously fast. That is why AV nodal blockers should be used in conjunction with flecainide and propafenone.  What is the role of cardioversion in atrial flutter management?  Due to high success rate with atrial flutter ablation, ablation is the first line treatment. However, sometimes cardioversion may be utilized in patients depending on how symptomatic they are and how long it will take to get an ablation. Cardioversion may also be utilized preferentially when the atrial flutter was triggered by infection or cardiac surgery to see if it will come back.   If cardioversion is pursued, the patient will need to be anticoagulated due to the stroke risk after the procedure due to post-conversion stunning.  How effective is atrial flutter ablation?  The landmark Natale et al study in 2000 demonstrated 80% success rate after radiofrequency ablation as compared to 36% in patients on anti-arrhythmic therapy. The LADIP study in 2006 further corroborated these findings. Contemporary data shows above 90% success rate of atrial flutter ablation.  In patients who have had both atrial fibrillation and atrial flutter, most electrophysiologists would ablate both. However, in patients with atrial fibrillation, the atrial flutter usually is initiated by trigger spots firing in the left atrium. Once the atrial fibrillation is ablated, the flutter will become less likely. Therefore, there are those who say there's no need to ablate the flutter circuit as well. Alternatively, if a patient has severe comorbidities and/or is high risk for ablation, one may consider performing the atrial flutter ablation only since atrial flutter is harder to manage medically compared with atrial fibrillation.   How do you manage atrial flutter in the acute inpatient setting?  In the inpatient setting, electrical cardioversion is often limited by blood pressure and the hypotensive effects of the sedatives required. If one is awake and too hypotensive, chemical cardioversion can be pursued. The most effective anti-arrhythmic for this is ibutilide. Amiodarone is not effective for acute cardioversion. Since ibutilide prolongs refractoriness in atrial and ventricular tissue, there's a risk of long QT induced torsades de pointes. Pretreating with magneisum reduces the risk to 1-2%.  References Jolly WA, Ritchie WT. Auricular flutter and fibrillation. 1911. Ann Noninvasive Electrocardiol. 2003;8(1):92-96. doi:10.1046/j.1542-474x.2003.08114.x  McMichael J. History of atrial fibrillation 1628-1819 Harvey - de Senac - Laënnec. Br Heart J. 1982;48(3):193-197. doi:10.1136/hrt.48.3.193  Lee KW, Yang Y, Scheinman MM; University of Califoirnia-San Francisco, San Francisco, CA, USA. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol. 2005;30(3):121-167. doi:10.1016/j.cpcardiol.200  2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e167. doi:10.1161/  Cosío F. G. (2017). Atrial Flutter, Typical and Atypical: A Review. Arrhythmia & electrophysiology review, 6(2), 55–62. https://doi.org/10.15420/aer.2017.5.2  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-11/Atrial-flutter-common-and-main-atypical-forms Natale A, Newby KH, Pisanó E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35(7):1898-1904. doi:10.1016/s0735-1097(00)00635-5  Da Costa A, Thévenin J, Roche F, et al. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114(16):1676-1681. doi:10.1161/CIRCULATIONAHA.106.638395  https://www.acc.org/Membership/Sections-and-Councils/Fellows-in-Training-Section/Section-Updates/2015/12/15/16/58/Atrial-Fibrillation#:~:text=The%20first%20'modern%20day'%20account,in%20open%20chest%20animal%20models.&text=In%201775%2C%20William%20Withering%20first,(purple%20foxglove)%20in%20AFib.

Advisors everywhere are feeling the pressure to scale, hire, and prepare for a wave of retirements that will reshape the industry. At the same time, firms are struggling to attract women, keep next-gen advisors engaged, and build teams that actually create freedom instead of more work.That's why I wanted to bring Lindsey Lewis on the show. After building a $200M book in her first year at Vanguard, Lindsey shifted her career toward research at The American College so she could help the profession fix its biggest blind spots—especially around women in finance, advisor retention, and the future talent pipeline.We dig into the data shaping the next decade of financial services: what women uniquely bring to advisory firms, why Gen Z is more interested in this profession than any generation before them, and how training, compensation, and career clarity determine whether young advisors stay or disappear.4 of the biggest insights from Lindsey …#1.) The Biggest Talent Gap in Advisor HistoryWe're staring down a generational shift in this profession. Tens of thousands of advisors are aging out. And when you run the math, the industry would need to hire over a million new people just to meet today's demand. Lindsey walks through the data behind this massive workforce gap and why the firms who build real training, career paths, and development now will be miles ahead of everyone else over the next decade.#2.) Women Advisors Are a Huge Missed OpportunityThe numbers don't lie: women make up 25% of CFPs… but only a small fraction are in sales/growth positions. And it's not a talent issue, it's how the industry has shaped roles, pay structures, and expectations over time. Lindsey breaks down why women often outperform in retention, personalization, referrals, and relationship depth, yet get pushed into service tracks or stay risk-averse because of cultural narratives, confidence gaps, or biases inside firms. The upside for the firms who fix this is enormous. Women represent one of the biggest untapped growth engines in financial services.#3.) Gen Z Wants In, But Poor Onboarding Pushes Them OutHere's the part no one expects: financial services is now Gen Z's top-preferred industry over tech and medicine. But at the same time, 1 in 4 early-career advisors say their onboarding wasn't effective — and those are the same people who leave within seven years. Lindsey lays out exactly what this generation needs to stay: mentorship, sponsorship, clear career paths, ongoing education, and roles that evolve with their confidence. If you want a talent pipeline that sticks, it starts with the first 12–18 months.#4.) Compensation Makes or Breaks Your TeamComp plans aren't just about money, they're about psychology. Young advisors need stability before they're ready to take on variable comp. Others crave upside and hate the idea of a flat salary. Lindsey explains the difference between income risk tolerance and income risk capacity, and why misalignment between the person and the pay structure is one of the biggest drivers of turnover. When firms get comp wrong, they churn through talent. When they get it right, people stay, grow, and eventually step into the very roles the industry is desperate to fill. SHOW NOTEShttps://bradleyjohnson.com/145FOLLOW BRAD JOHNSON ON SOCIALTwitterInstagramLinkedInFOLLOW DBDL ON SOCIAL:YouTubeTwitterInstagramLinkedInFacebookDISCLOSURE DBDL podcast episode conversations are intended to provide financial advisors with ideas, strategies, concepts and tools that could be incorporated into their business and their life. No statements made in the episode are offered as, and shall not constitute financial, investment, tax or legal advice. Financial professionals are responsible for ensuring implementation of anything discussed related to business is done so in accordance with any and all regulatory, compliance responsibilities and obligations. The Triad member statements reflect their own experience which may not be representative of all Triad Member experiences, and their appearances were not paid for. Triad Wealth Partners, LLC is an SEC Registered Investment Adviser. Please visit Triadwealthpartners.com for more information. Triad Wealth Partners, LLC and Triad Partners, LLC are affiliated companies. TP11254981366See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Discover how artificial intelligence is revolutionizing heart disease prevention and treatment with Dr. Ami Bhatt, Chief Innovation Officer at the American College of Cardiology.From AI-powered early detection tools to personalized risk prediction, learn how new technologies are making quality cardiac care more accessible while preserving the essential human element of medicine. Dr. Bhatt shares fascinating insights about the innovations transforming cardiovascular health today and her vision for even more remarkable advances coming in the next five years.You can find Ami at: Website | LinkedIn | Episode TranscriptIf you LOVED this episode, don't miss a single conversation in our Future of Medicine series, airing every Monday through December. Follow Good Life Project wherever you listen to podcasts to catch them all.Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.